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          MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene 
expression. miRNAs play multiple functions in many essential cellular processes such as 
proliferation, apoptosis and differentiation.  
          Autophagy is a conserved cellular process in which cell digests spent components and 
organelles to regenerate energy and “building blocks” to cope with various kinds of stress.  
          To date, the effect of autophagy on miRNA expression and the corresponding mechanisms 
through which miRNAs regulate autophagy are still not clear. Therefore, the main objective of 
this study is to investigate the effect of autophagy induction on endogenous miRNA expression 
and the corresponding mechanisms through which miRNAs regulate autophagy. 
          Here, we first screened the differential expression of miRNAs by microarray when 
autophagy was induced by starvation in Atg5 wide type mouse embryonic fibroblasts (WT MEF) 
and Atg5 knock out mouse embryonic fibroblasts (KO MEF). Starvation and Rapamycin 
treatments are established common inducers for autophagy. The MEF cells were chosen as they 
were among the most popular cell line models for the current autophagy research, knock out of 
Atg5 can efficiently block autophagy induced by starvation or Rapamycin. Among these 
miRNAs, miR-93 and miR-181a were up-regulated while miR-221 was down-regulated when 
autophagy was induced.  Such changes were confirmed using real time qRT-PCR in cells 
undergoing autophagy induced by either starvation or Rapamycin. Those miRNAs  deregulated 
in the period of autophagy induction  were predicted to target a variety of autophagy related 
genes, indicating the important regulatory role of miRNAs in autophagy. 
 x 
 
           miR-93 was selected for further examination. Through screening of the predicted 
autophagy related target genes, we successfully identified Ulk1 as a novel target gene of miR-93, 
based on the following evidence: (1) Compared with MEF cells transfected with negative control 
miRNA, the expression levels of Ulk1 protein and mRNA in MEF cells transfected with pre- 
miR-93 were decreased whereas they were relatively more abundant in MEF cells transfected 
with anti-miR-93. (2) Through ß-Gal reporter gene assay, miR-93 was proved to interact with the 
predicted binding sites on the 3'UTR of Ulk1 mRNA. Since Ulk1 is an essential Atg gene which 
forms a complex with mammalian orthologue of Atg13 and FIP200 during the initiation of 
autophagosome formation, miR-93 places its negative regulatory effect on autophagy initiation 
through suppression of Ulk1 expression.  
           In summary, this study reveals a new negative feedback loop mechanism between 
autophagy and miR-93. Data from this study provided new evidence that certain miRNAs could 
play important roles in autophagy via regulation of key Atg genes such as Ulk1. Understanding 
such a novel mechanism is beneficial for the development of miRNA-based therapeutics against 
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Chapter 1   Introduction 
 
1.1 Autophagy:  
 
In order to achieve cellular homeostasis which favors cell survival and normal 
growth, besides the regular synthesis of macromolecule and organelles, cells must also 
adopt several degradation mechanisms. The major turnover pathway for cytosolic protein is 
the proteasome pathway while the major degradation pathway for bulk cellular components 
is Autophagy - the “self-eating” pathway.  
In mamalian cells, there are mainly three types of autophagy: macroautophagy, 
microautophagy and chaperone-mediated autophagy. Chaperone-mediated autophagy is a 
secondary response to starvation which involves direct translocation of the protein cargoes 
across the lysosome membrane (Massey et al., 2006). Microautophagy sequesters 
cytoplasm by invagination or septation of the lysosomal/vacuolar membrane (Wang and 
Klionsky, 2004). Macroautophagy (hereafter refer to as autophagy), the most prevalent 
form, is morphologically featured by the formation of autophagosomes. Autophagy, is a 
highly conserved cellular process in which double-membrane autophagosomes sequester 
spent organelles or unwanted cellular components and fuse with lysosomes for degradation 
and recycling (Klionsky and Emr, 2000). 
Autophagy is a highly dynamic process which includes several discrete steps: (1). 
induction; (2). cargo selection and packaging; (3). nucleation of vesicle formation; (4). 
vesicle expansion and completion; (5). retrieval; (6). fusion with endosome and 
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lysosome/vacuole; (7). breakdown of intralumenal cargoes and recycling (Klionsky, 2005).  
The dynamic autophagy process is briefly illustrated in Figure 1.1. 
         Autophagy is induced by various cellular cues such as amino acid deprivation, 
hypoxia and growth factor withdrawal. After receiving autophagy-inducing signals, the 
autophagosomes will be de novo generated (Yorimitsu and Klionsky, 2005). After the Atg1 
complex triggered initiation, the phagophore (PAS) will be formed via the nucleation 
machinery (Xie et al., 2008). Through elongation machinery, the phagophore develops into 
autophagosome. Then the matured autophagosome, by fusing with endosome and 
lysosome/vacuole sequentially, becomes autolysosome in which the contents are degraded 
and recycled. 
               
                                                           
Figure 1 .1  Schematic depiction of the dynamic process of autophagy  




          1.1.1 Atgs: the autophagy machinery  
 
Autophagy is a highly evolutionarily conserved process and autophagy-related (Atg) 
genes are found in almost all organisms from monocellular yeasts to fungi, drosophila up to 
vertebrates. Since the first discovery of Atg1 gene in yeast (Matsuura et al., 1997), to date, 
32 Atg genes have been identified in yeast and there are 15 known counterparts in 
mammalian cells (He and Klionsky, 2009; Kanki et al., 2009; Tanida et al., 2011). 
Among these Atg genes, 18 of Atg genes (Atg1–10, Atg12–14, Atg16–18, Atg29, 
and Atg31) are involved in autophagosome formation (Mizushima, 2007). As this study is 
conducted using MEF cells, the functions of mammalian Atg genes for the autophagy core 
machinery is summarized in Table 1.1. 
 
      Table 1.1 Fuctions of mammalian Atg genes in the autophagy core machinery  
Mammals Yeast Functions            References 
Ulk1/2 Atg1 
protein kinase, target of mTOR kinase and AMPK, form 
a complex with Atg13, Atg17,and Atg101, trigger 
autophagosome biogenesis 
(Chan et al., 2007; 
Hara et al., 2008; 
Young et al., 2006) 
Atg3 Atg3 E2-like enzyme in Atg12 and Atg8/LC3 conjugation 
(Ichimura et al., 2000; 
Tanida et al., 2006) 
Atg4A-D Atg4 
cytosolic cysteine protease for processing of Atg8/LC3, 
deubiquitinating-like enzyme for removing PE from 
Atg8 
(Marino et al., 2003; 
Scherz-Shouval et al., 
2003; Tanida et al., 
2004) 
Atg5 Atg5 target of Atg12 localizing to isolated membranes, (Mizushima et al., 
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leading to oligomerization with Atg16 to form a 
complex acting as a E3-like enzyme involved in Atg8 
lipidation 
1998a; Mizushima et 
al., 2001) 
BECN1 Atg6 
interact with PI3K class III required for membrane 
nucleation, Bcl2-interacting protein 
(Liang et al., 1999; 
Kametaka et al., 1998) 
Atg7 Atg7 
E1-like enzyme for Atg12-Atg5 conjugation and Atg8 
lipidation 





Atg8 conjugating with PE and localizing to autophagosomes 
(Kabeya et al., 2000; 
Tanida et al., 2006) 
Atg9A/B Atg9 
transmembrane protein involved in autophagosome 
formation 
(Yamada et al., 2005; 
Young et al., 2006) 
Atg10 Atg10 E2-like enzyme for Atg5-Atg12 conjugation 
(Mizushima et al., 
2002) 
Atg12 Atg12 
conjugates with Atg5, leading to oligomerization with 
Atg16 to form a complex act as  E3-like enzyme that 
involved in Atg8 lipidation 
(Mizushima et al., 
1998b) 
Atg13 Atg13 phosphorylated protein in the Ulk1 complex 
(Hosokawa et al., 
2009; Meijer et al., 
2007) 
Atg14/Barkor Atg14 
bind with Beclin 1-PI3K class III (Vps34) complex 
involved in membrane nucleation, enhance 
autophagosome formation 




interact with Atg5-Atg12 to form complex acting as a 
E3-like enzyme,determines the site of LC3 conjugation 
(Mizushima et al., 
2003) 
FIP200 Atg17 
component of the Ulk1 complex, essential for both 
stability and phosphorylation of Ulk1 
(Ganley et al., 2009; 
Hara et al., 2008; Jung 
et al., 2009) 
WIPI-1,2,3,4 Atg18 PI(3)P binding protein, involved in nucleation 
(Proikas-Cezanne et 
al., 2004) 
Atg101   
important for stability and basal phosphorylation of 
Atg13 and Ulk1 
(Hosokawa et al., 
2009; Mercer et al., 
2009) 
 
The existence of Atg5/ Atg7-independent alternative macroautophagy shows that 
autophagy is a very complex and finely controlled process (Nishida et al., 2009). 
 
1.1.1.1 The Atg1 (Ulk1) complex in autophagy induction 
 
Atg1, a serine/threonine kinase, has been proved to play an indispensable role in this 
process. In yeast, the Atg1 complex, consisting of Atg1, Atg13, and Atg17, is the 
downstream of the target of Rapamycin (TOR) and cAMP-dependent kinase (PKA) 
pathways (Matsuura et al., 1997). Upon TOR inhibition, both the Atg1 kinase activity and 
its binding affinity to Atg13 and Atg17 increase, leading to formation of an Atg1-Atg13-
Atg17 scaffold and recruitment of multiple Atg proteins to the Pre-autophagosome 
Structure (PAS) to initiate autophagosome formation (Kamada et al., 2000). In addition, 
Atg1 kinase activity is suggested to be primarily required for the Cvt pathway (Abeliovich 
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et al., 2003). Moreover, in Drosophila, during nutrient starvation, Atg1 can inhibit the 
phosphorylation and activation of S6K, a downstream effector of TOR (Lee et al., 2007). 
There are two mammalian Atg1 homologs - unc-51-like kinase 1 and 2 (Ulk1 and 
Ulk2), which have been found to form a complex with mammalian orthologue of Atg13 
and Atg17 (FIP200) and localize to the phagophore upon starvation (Hara et al., 2008; Jung 
et al., 2009).  Different from the Atg1 complex components in yeast, Ulks, Atg13 & 
FIP200 form a stable complex in a nutrient-independent manner in mammalian cells and 
Atg13 and FIP200 are required for maximizing Ulk1 kinase activity (Ganley et al., 2009; 
Hosokawa et al., 2009; Jung et al., 2009). 
Under nutrient-rich conditions, mTOR complex 1 (mTORC1) interacts with the 
Ulk1-Atg13-FIP200 complex through raptor, one of the mTORC1 components, and 
sequentially phosphorylates and inactivates Ulks and Atg13 (Ganley et al., 2009; Jung et 
al., 2009). Upon mTORC1 inhibition, Ulk1 and Ulk2 are freed and phosphorylate Atg13 
and FIP200, which are essential for promoting autophagy (Hara et al., 2008; Hosokawa et 
al., 2009). Atg101, a newly identified component in the Ulk1 complex in mammals, binds 
and stabilizes Atg13 (Mercer et al, 2009). 
Besides their phospohorylation effect on Atg13 and FIP200, Ulks also undergo 
autophosphorylation which results in conformational changes and autophagy induction 
(Chan et al., 2009). 
Recently, Ulk1 and Ulk2 were found to be substrates of  AMPK  and similar to 
mTORC1, AMPK  also associated with Ulk1 in a nutrient-dependent manner  (Egan et al., 
2011a; Lee  et al., 2010; Shang et al., 2011 ). However, AMPK may have dual role in 
autophagy induction as on one hand, during starvation, besides the classic AMPK-TSC1/2-
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mTOR pathway, it can also phosphorylate raptor, the key adaptor in mTORC1, thus lifting 
the inhibitory effect of mTOR on Ulk1 (Lee et al., 2010; Egan et al, 2011b); on the other 
hand, when cells are fed, it can form a complex with and confine portions of Ulk1 to 
suppress autophagy (Shang et al., 2011). Interestingly, Ulk1 and Ulk2 were also shown to 
be able to in turn phosphorylate AMPK and thereby form a negative feedback circuit 
(Löffler et al., 2011). These studies show the fact that Ulks are  tightly under the control of 
multiple signaling pathways in mammalian cells. 
 
1.1.1.2 The class III phosphatidylinositol 3-kinase (PtdIns3K) complex in PAS nucleation 
 
Instead of being generated by budding from a preexisting organelle's surface or 
sealing of a piece of continuous membrane, autophagosome is assembled at the PAS by 
adding new membranes. In the early stage of autophagosome formation - the nucleation 
and initial assembly of the phagophore membrane require the participation of the class III 
phosphatidylinositol 3-kinase (PtdIns3K) complex which produces PI3P from PI. It is also 
involved in PAS targeting of Atg18 (WIPI-1α), Atg20, Atg21, and Atg24 that bind 
PtdIns3P (Nice et al., 2002; Obara et al., 2008; Stromhaug et al., 2004; Axe et al., 2008; 
Proikas-Cezanne et al., 2004) and thus further recruits two ubiquitin-like (Ubl) conjugation 
systems, Atg12–Atg5-Atg16 and Atg8–PE, to the phagophore, contributes to the 
membrane elongation (Suzuki et al., 2001; Suzuki et al., 2007). 
In yeast, the class III PtdIns3K complex is composed of the PtdIns3K Vps34 
(vacuolar protein sorting 34), a myristoylate serine/threonine kinase Vps15, Atg14 and 
Atg6 (Kihara et al., 2001). In mammals, the class III PtdIns3K complex includes Beclin 1, 
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hVps34, hVps15 (formerly called p150), and Ambra1 (Fimia et al., 2007). Similar to its 
yeast counterpart, this complex also binds to Atg14 (Barkor) (Sun et al., 2008) and 
participates predominantly in autophagy regulation (Itakura et al., 2008). There exists 
another Beclin 1-hVps34 complex which comprises Beclin 1, hVps34, hVps15, Ambra1 
and additionally, the mammalian homolog of Vps38 and the UV irradiation resistance-
associated gene (UVRAG) protein whose role in autophagy is still not clear. UVRAG was 
observed to be able to activate Beclin 1-hVps34 complex and facilitate autophagosome 
formation (Liang et al., 2006; Takahashi et al., 2007), while other studies found that the 
UVRAG-incorporated Beclin 1-hVps34 complex was not involved in autophagosome 
formation (Itakura et al., 2008; Sun et al., 2008) but regulation of autophagosome 
maturation and endocytotic trafficking (Liang et al., 2008).  
Beclin 1 is the mammalian homologue of the yeast Atg6, which was found to be 
indispensible for autophagy in mammals (Liang et al., 1999). Under nutrient-rich 
conditions, Beclin 1 is bound by the anti-apoptotic protein B-cell lymphoma/leukemia-2 
(Bcl2) and thus autophagy is suppressed. Dissociation of Bcl2 from Beclin 1 is required for 
the autophagy induction. The activity of Vps34 (hVps34) is tightly controlled by Vps15 
(hVps15) (Stack et al., 1995; Yan et al., 2009). Beclin 1 was reported to strengthen the 
interaction between hVps34 and hVps15 and thus activate hVps34 (Yan et al., 2009). 
      
1.1.1.3 Two ubiquitin-like systems in membrane elongation 
 
Two ubiquitin-like systems, the Atg5-Atg12 system and the Atg8 (LC3) system, are 
evolutionarily conserved from yeast to mammals and play essential roles in autophagosome 
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biogenesis. Like ubquitination in which ubquitin is first activated and transferred by an E1 
ubiquitin-activating enzyme to an E2 ubiquitin-conjugating enzyme, and then conjugated 
with the target protein by an E3 ubiquitin-protein ligase (Pickart, 2004), the two ubiquitin-
like system also undergo conjugation in a similar manner.  
In the Atg5-Atg12 system, Atg12 is activated by Atg7 (E1), transferred to Atg10 (E2) 
and attached to the substrate protein Atg5. In contrast to ubiquitination, Atg12-Atg5 
conjugation does not require E3 ligase counterpart (Geng and Klionsky, 2008) and the 
conjugate further interacts with Atg16, a coiled-coil protein which links the Atg12-Atg5-
Atg16 complex into a tetramer through self-oligomerization and localizes to the 
phagophore (Mizushima et al., 2003). 
 In the LC3 conjugation system, the newly synthesized LC3 is first processed by a 
cysteine protease, Atg4, exposing a C-terminal glycine residue to generate LC3-I.  Atg7 
activates LC3-I and transfers it to Atg3 (E2). LC3-I is finally conjugated to the 
phosphatidylethanolamine (PE), catalyzed by the E3-like Atg12-Atg5 conjugate which is 
the product of the other Ubl system described above (Ichimura et al., 2000). PE conjugated 
LC3-II is requried for the elongation of autophagic membrane. Upon autophagy induction, 
LC3 will rapidly change from the cytosolic form to the lipid-conjugated form and 
translocate to both sides of the PAS (Kabeya et al., 2000). After autophagosome formation, 
LC3-II on the outter membrane will be released and recycled while the inner membrane-
anchored LC3-II will be degraded in the autolysosome (Mizushima et al., 2003). 
 




Atg9 is the only identified integral membrane protein during the autophagosome 
formation. It may function as a vesicle in supplying membrane and may also exert its effect 
on phagophore expansion. Atg9 is found to be localized to the PAS and non-PAS 
membranes (peripheral structures in yeast, trans-Golgi network and endosomes in 
mammal). Researchers have found that Atg9 can move bidirectionally between these two 
sites (Young et al., 2006) and this membrane cycling machinery is believed  to deliver 
membranes to PAS thus facilitates the autophagosome formation (Reggiori et al., 2005; 
Reggiori et al., 2004a). In yeast, Atg11, Atg23, and Atg27 assist the anterograde transport 
of Atg9 to phagophore (Chang et al., 2007a; He et al., 2006; Legakis et al., 2007; Yen et al., 
2007); while the Atg1 complex, Atg2, Atg18, and the PtdIns3K complex are essential in its 
retrograde transport (Reggiori et al., 2004a). In mammals, similarly, when autophagy is 
induced, Atg9 is transported from the trans-Golgi network (TGN) to late endosomes and 
Ulk1 and Atg13 are essential in the redistribution of Atg9 from the TGN to late endosomes 
(Young et al., 2006). Also, dynamic self-multimerization of Atg9 was suggested to 
facilitate membrane tethering or fusion during phagophore expansion (He et al., 2008). In 
addition, the interaction between Atg9 and Atg18 which links the membrane cycling 
machinery to the nucleation machinery was also reported (Reggiori et al., 2004b). 
 
         1.1.1.5 The Beclin 1-hVps34 - Rubicon complex in the late stages of autophagy 
 
After formation, autophagosomes will fuse with early or late endosomes to form the 
amphisomes, and subsequently fuse with the lysosomes to form the autolysosomes (Liou et 
al., 1997;  Razi et al., 2009; Stromhaug et al., 2004).  As a result, the acidification of the 
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autophagosome and the degradation and recycling of cellular components were also 
observed.  
Multiple signals mediate the late stages of autophagy.  In addition to the 
autophagosome formation function of the Beclin 1-hVps34 - Rubicon complex mentioned 
previously, this complex also regulates the maturation of autophagosome. The Beclin 1-
hVps34 - Rubicon complex was proposed to upregulate the endocytic trafficking and the 
maturation while its association with Rubicon would downregulate these trafficking events  
(Matsunaga et al., 2009; Zhong et al., 2009). Besides this, the maturation of 
autophagosome is regulated by Rab proteins, DRAM as well as the endosomal and 
lysosomal membrane proteins while the kinase activity of ATPases is essential for the 
acidification and degradation stages (Mehrpour et al., 2010).  
 
         1.1.2 Upstream signaling pathways for regulation of autophagy 
 
Since autophagy is such a crucial process in controlling cell death and survival in 
response to environmental cues during stress periods, it is not a surprise that there are 
multiple pathways involved in the regulation of  intracellular autophagic activity including 
nutrient & energy signaling pathways, various stress response pathways, and pathogen 
infection related signaling pathways (He and Klionsky, 2009). As mTOR is in the central 
point of various pathways that sensing nutrient status, growth factors, energy balance and 
environmental stresses, it plays a crucial role in the upstream signaling network of 
autophagy (Schmelzle and Hall, 2000). The upstream signaling pathways regulating 



































































































The major pathways are discussed below. 
  
1.1.2.1  mTOR complex 1 pathways 
 
There are two mTOR complexes in mammals. mTOR complex 1 (mTORC1), 
comprising of mTOR, raptor, mLST8 (also known as GβL), is sensitive to inhibition by 
Rapamycin. Rapamycin stimulates autophagy by inhibiting mTORC1 even in the presence 
of nutrients (Noda and Ohsumi, 1998).  In contrast, mTORC2 which consists of mTOR, 
sin1, rictor and mLST8, is not known to be resistant to Rapamycin and its involvement in 
autophagy is largely unknown. 
Activation of mTORC1 leads to phosphorylation of Ulk1 and Atg13 at the inhibitory 
sites, blocks the Ulk1 complex's role in autophagosome induction and thus suppresses 
autophagy. Besides this, mTORC1 also suppresses autophagy through phosphorylation of 
Tap42, an activator of the catalytic subunits of PP2A (the serine/threonine protein 
phosphatase 2A) which is a negative regulator of autophagy (Yorimitsu et al., 2009). 
Activation of mTORC1 also leads to phosphorylation of S6K1 and 4E-BP1 which 
promotes protein translation and  transcription of many genes via modulation of URI 
(unconventional prefoldin RPB5 interactor) and transcription factors, e.g. STAT1 and 
STAT3 (Wullschleger et al., 2006).  
Withdraw of growth factors alone is sufficient to induce autophagy (Lum et al., 
2005a). Growth factors such as insulin and  insulin-like growth factors exert their 
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regulatory fuction via modulating mTOR activity. Ligation between insulin and its receptor 
leads to activation of Class I PI3K and generation of PIP3 (phosphatidylinositol (3,4,5)-
trisphosphate) which result in the full activation of Akt by PDK1 and mTORC2 (Jacinto et 
al., 2006; Sarbassov et al., 2005). Activated Akt in turn phosphorylates TSC2 and leads to 
TSC1-TSC2 complex's dissociation, maintaining the GTP-Rheb (Inoki et al., 2002; Tee et 
al., 2002; Tee et al., 2003) which activates mTORC1 subsequently (Inoki et al., 2003; Li et 
al., 2004; Long et al., 2005). Additionally, activated Akt also phosphorylates PRAS40 and 
thus dissociates the inhibitory 14-3-3 from mTORC1 (Vander Haar et al., 2007). PTEN 
reverses PIP3 production and sequentially decreases the downstream PKB/Akt signaling 
that negatively regulates autophagy (Arico et al., 2001). Akt inactivation also leads to 
activation of the forkhead box O (FoxO) transcription factors 3 (FoxO3) which amplifies a 
variety of autophagy-related genes including LC3, BNIP3, Atg4, and hVps34 (Mammucari 
et al., 2007; Zhao et al., 2007). 
Besides this, Ras is also involved in the growth factor pathway. In NIH3T3 mouse 
embryonic fibroblasts (MEFs), growth factor receptor (tyrosine kinases) activated Ras 
decreases autophagy via the Class I PtdIns3K, but not through Raf-1 (Furuta et al., 2004). 
Recent studies are elucidating the mechanisms how nutrients, especially essential 
amino acids, activate mTORC1. Rag proteins, the Ras-related small GTPases, activate 
TORC1 in response to amino acids in Drosophila and mammals (Kim et al., 2008a; Sancak 
et al., 2008) through translocation of mTORC1 which facilitates the interaction between 
TORC1 and its activator Rheb (Ras homolog enriched in brain) (Sancak et al., 2008).  The 
observation that single amino acid fails to activate mTORC1 (Hara et al., 1998) can be 
explained by the fact that in the upstream of Rag protein, SLC1A5 and SLC7A5, the 
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bidirectional transporter, simultaneously promote the efflux of L-glutamine  and the influx 
of L-leucine/EAA across cell membranes (Nicklin et al., 2009). Sancak et al. recently 
identified that Ragulator - a complex including the MAPKSP1, ROBLD3, and c11 or f59 
genes, associates with the Rag GTPases and it is essential for the translocation of mTORC1 
to lysosomal membranes in response to amino acids (Sancak et al., 2010). In addition, p62 
was discovered to be interacting with raptor thus it is an integral part of the mTORC1 
complex. p62 was proved to be responsible for the activation of S6K1 and 4EBP1 and its 
interaction with mTOR and raptor is amino-acid dependent. The interaction and 
colocalization of p62 and Rags at the lysosomal compartment is essential for the interaction 
of mTOR with Rag GTPases and subsequent translocation of the mTORC1 complex to the 
lysosome (Duran et al., 2011). 
On the other hand, other studies found that amino acid also could activate mTOR and 
subsequent autophagy inhibition through the effect of class III PtdIns3K (Byfield et al., 
2005; Nobukuni et al., 2005) which makes class III PtdIns3K's effect on autophagy a bit 
confusing. 
 
          1.1.2. 2 The Ras-cAMP-PKA pathway 
 
In glucose sensing, the Ras-cAMP-PKA pathway plays a crucial role. Without 
starvation, the active small GTPases Ras1 and Ras2 enhance generation of cAMP which 
binds to Bcy1 and releases its inhibitory effect on PKA. In yeast, constitutively activated 
Ras-cAMP-PKA pathway suppresses autophagy induced by TOR inhibition though 
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phosphorylation of PKA's substrate Atg1 (Budovskaya et al., 2004;  Budovskaya et al., 
2005;  Schmelzle et al., 2004). 
    
1.1.2.3 AMPK signaling pathway 
 
 AMP-activated protein kinase (AMPK) is activated by an increased ratio of 
AMP/ATP via its upstream kinase LKB1 (Corradetti et al., 2004; Hardie et al., 1998). 
Activated AMPK leads to direct phosphorylation of TSC2 which stabilizes the TSC1-TSC2 
complex, thereby maintains GDP-Rheb and eventually suppresses mTORC1 (Inoki et al., 
2003b). Alternatively, AMPK also phosphorylates raptor, facilitates sequestration of raptor 
by 14-3-3, thus suppresses mTORC1 activity (Gwinn et al., 2008). In addition, the LKB1-
AMPK pathway phosphorylates and activates p27kip1, which is required for autophagy 
induction in response to bioenergetic stress during growth factor withdrawal and nutrient 
deprivation (Liang et al., 2007). The yeast homolog of mammalian AMPK, Snf1, also 
positively monitors autophagy, but through an independent mechanism involving Atg1 
(Wang et al., 2001). As previously mentioned, Ulk1 is also a substrate of AMPK in 
mammal. When cells are fed, it can form a complex with and confine portions of Ulk1 to 
suppress autophagy (Shang  et al., 2011) whereas upon starvation, AMPK can 
phosphorylate raptor to lift the inhibitory effect of mTOR on Ulk1 (Lee et al., 2010; Egan 
et al, 2011). Also, AMPK was shown to be negatively feedbacked by Ulk1 and Ulk2 
(Löffler et al., 2011).  
 




          1.1.2.4.1 Hypoxia  
 
 Hypoxia, an atmosphere in which levels of oxygen is at or below 1% (Warnecke et 
al., 2003; Persson et al., 2011), induces autophagy in mammalian cells. Hypoxia-inducible 
factor-1 (HIF-1) is the primary transcription factor acutely induced by hypoxic conditions 
which helps to minimize deleterious effects caused by O2 deficiency. In MEFs, hypoxia 
induced mitophagy is dependent on HIF-1 and its downstream target BNIP3 and BNIP3L 
(Zhang et al., 2008a; Sandoval et al., 2008; Schweers et al., 2007). BNIP3 competes with 
Beclin 1 for Bcl-2 binding and thus decreases Bcl-2's inhibitory effect on autophagy. 
Interestingly, in tumor cells, hypoxia induced bulk autophagy is not dependent on the HIF-
1 pathway but the AMPK-mTOR and PKCδ -JNK1 pathway (Papandreou et al., 2008; 
Vasseur et al., 2009; Chen et al., 2008a). Also, TOR, the eIF4F complex and mRNA 
translation are inhibited by hypoxia (Brugarolas et al., 2004; Reiling and Hafen, 2004 ). 
However,  autophagy seems to have dual functions in hypoxia, enhanced mitophagy   
reduces reactive oxygen species (ROS) and protects cell integrity, while in several cancer 
cell lines, prolonged hypoxia mediates autophagic cell death (Azad et al., 2008). 
 
          1.1.2.4.2 ER stress  
 
ER stress is a common inducer of autophagy which can be accumulated by glucose 
deprivation, hypoxia, oxidative stress and Ca
2+
 efflux. In yeast, ER stress-induced 
autophagy is mediated by Ire1 (inositol-requiring kinase 1), an ER transmembrane protein 
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with a cytosolic endoribonuclease domain. When unfolded proteins accumulates in the ER, 
an ER-specific member of the heat shock protein 70 family, Grp78/BiP, activates the 
cytosolic endonuclease activity of Ire1,  triggers the splicing of its substrate Hac1 and then 
subsequently  activates transcription of Hac1's target genes involved in protein 
modification/folding (Ma and Hendershot, 2001).  Similarly, in mammals, siRNA 
downregulation of  Grp78/BiP inhibits autophagosome formation induced by ER stress (Li 
et al., 2008). The mammalian signaling network in response to ER stress is more complex 
including at least three distinct downstream pathways: IRE1-JNK pathway (Ogata et al., 
2006), ATF6 (activating transcription factor 6) pathway, and PERK (RNA-dependent 
protein kinase-like ER kinase) - eIF2α pathway (Kouroku et al., 2007). ER stress also 
increases the intracellular Ca
2+
 level and activates Calcium-activated calmodulin-dependent 
kinase kinase-β (CaMKKβ) which activates AMPK (Høyer-Hansen et al., 2007). Also, 
increased Ca
2+ levels leads to phosphorylation of PKCθ that induces LC3 conversion and 
autophagy (Sakaki et al., 2008). 
 
          1.1.2.4.3 ROS and oxidative stress 
 
ROS, the destroyer of organelles such as mitochondria, is another common inducer 
of autophagy, especially, mitophagy (Narendra et al., 2008; Priault et al., 2005). ROS can 
cause oxidation of a conserved Cys81 on Atg4 and thereby inhibit Atg4 protease activity 





1.1.3 Biological functions of autophagy 
   
As a cellular degradative pathway in eukaryotes which relieves cells from various 
types of stresses, autophagy has a variety of physiological and pathological roles such as 
starvation adaptation, intracellular protein and organelle clearance, development, anti-
aging, elimination of microorganisms, cell death, tumor suppression and antigen 
presentation (Mizushima et al., 2005). 
Among them, the pro-survival or pro-death function of autophagy has been studied 
extensively and the conclusion remains highly controversial. So far, there is still not a 
general conclusion about autophagy’s role in PCD, it can be pro-survival or pro-death, or 
even just a bystander as the cell death mechanisms when autophagy is also present are cell 
line specific and highly dependent on stimulus (Kourtis and Tavernarakis, 2009; Kroemer 
and Levine, 2008; Levine and Yuan, 2005). 
For example, the relationship between autophagy and apoptosis is complex as a 
number of inducers such as etoposide (Feng et al., 2005) and ceramide (Pattingre et al., 
2009) can activate apoptosis and autophagy simultaneously and the fact that there is a lot 
of crosstalk between these two processes that maintain cell integrity and homeostasis by 
eliminating damaged and aged cells or spent cellular components.  
 
           1.1.3.1 The pro-survival function of autophagy 
 




In spite of its pro-death function, autophagy also has been proved to be a protective 
mechanism in various cellular settings to help cell survive through stress times, especially 
under nutrient deprivation. For example, autophagy can decrease apoptosis induced by ER 
Stress (Bernales et al., 2006; Ding et al., 2007a; Ogata et al., 2006) and DNA damage (Ito 
et al., 2005; Paglin et al., 2001). 
 It is simple to understand that autophagy helps cell cope with tough conditions by 
providing recycled energy and nutrients. Similar to starvation induced autophagy which 
digests bulk cytosolic components to provide energy and metabolite supply, DNA-damage 
induced autophagy also maintains the intracellular ATP level and thus promotes cell 
survival (Lum et al., 2005b; Katayama et al., 2007). This notion is also supported by in 
vivo models, the lack of survival of Atg5/Atg7 defective mouse through the neonatal 
period again demonstrates the crucial pro-survival function of autophagy (Komatsu et al., 
2005; Kuma et al., 2004). 
Autophagy also acts as a housekeeper to help cell specifically eliminate spent 
harmful organelles such as damaged mitochondria by ROS which can serve as triggers for 
apoptosis (Lemasters, 2005; Ravikumar et al., 2006). Misfolded protein aggregates which 
cause ER stress are also cleaned by autophagy (Ding et al., 2007b). 
 
           1.1.3.1.2 Autophagy suppresses necrosis 
 
Numerous studies have reported that autophagy acts as a protective mechanism in 
necrosis and unlike apoptosis, it does not require energy supply at its late stage. For 
example, knockdown of Atg5 in the Bax-/- & Bak-/- MEF cells when growth factor is 
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withdrawn causes the cells to undergo rapid necrosis (Lum et al., 2005a). Upon the signal 
of metabolic stress, suppression of autophagy by activated Akt or disrupted Beclin 1 
sensitizes cancer cells to necrosis (Degenhardt et al., 2006) as autophagy maintains 
genome integrity by eliminating the harmful effect of DNA damage in such cells context 
(Karantza-Wadsworth et al., 2007). Colell et al. also found that  autophagy and 
upregulation of glycolysis induced by GAPDH protected cells from necrosis (Colell et al., 
2007). 
 
           1.1.3.2 The pro-death function of autophagy 
 
           1.1.3.2.1 Autophagy promotes apoptosis 
 
Apoptosis is attenuated when autophagy is suppressed by 3-methyladenine (3-MA) 
or knockdown of Atg7 and Beclin 1 in CD4+ T lymphocytes and leukemia cell lines 
(Espert et al., 2006). Autophagy is induced by cannabinoid via ER-stress response which is 
also the upstream signal of cannabinoid-induced apoptosis in cancer cell lines (Salazar et 
al., 2009). The pro-death function of autophagy may be executed through various 
pathways such as Akt and ERK, Atg5, Bcl-2 family members. Akt is able to inhibit 
apoptosis via phosphorylation of Bad and suppression of transcription factor FoxO (Brunet 
et al., 1999; Datta et al., 1997). Likewise, ERK also can phosphorylate Bad and activate 
another transcription factor CREB that amplifies anti-apoptosis proteins (Ballif and Blenis, 
2001). Thus, during autophagy, the suppression of Akt and ERK may lead to promotion of 
apoptosis. The calpains-cleaved form of Atg5, one key member of the core autophagy 
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machinery, has been found to translocate from cytosol to mitochondria to promote 
cytochrome c release and intrinic apoptosis pathway (Yousefi et al., 2006). 
 It was proposed that the anti-apoptosis Bcl-2 proteins such as Bcl-2, Bcl-xL, and 
Mcl-1 could bridge the pro-death function of autophagy in apoptosis as Beclin 1 may 
sequester anti-apoptotic Bcl-2 proteins. However, the Beclin 1-bound Bcl-2 family 
proteins are still fully anti-apoptotic (Ciechomska et al., 2009). Qu et al. found that in the 
embryoid bodies defective in autophagy, the induction of apoptosis did not require 
autophagy but in the late stage of apoptosis, the energy synthesised from autophagy was 
crucial for the completion of the apoptosis machinery (Qu et al., 2007; Kroemer and 
Levine, 2008). 
 
           1.1.3.2.2 Autophagy itself serves as a death mechanism: autophagic cell death 
 
Paradoxically, although autophagy plays primarily a pro-survival function, it can 
also accelerate cell death during necrosis. Autophagic cell death describes a cell death 
mechanism that is dependent on autophagy but independent on caspases, in which 
autophagy is the executioner rather than just a bystander (Kroemer et al., 2009).  And it 
was evidenced in several in vitro models, Shimizu et al. found that in response to DNA 
damage caused by etoposide and staurosporine, the Bax-/- & Bak-/-  MEF cells underwent 
a non-apoptotic cell death dependent on autophagy as decreasing Atg5 or Beclin 1 could 
preserve cell viability (Shimizu et al., 2004). Another group identified in several cell lines 
such as fibrosarcoma L929 cells, the non-apoptotic cell death induced by zVAD, a pan-
24 
 
caspase inhibitor, was autophagy dependent as silencing Beclin 1 and Atg7 ablated cell 
death, but  futher  examination of  the detailed mechanisms are  needed (Yu et al., 2004).  
Yet, the evidences for this kind of cell death in vivo systems are still not 
convincing, for example, in D. discoideum lacking Bcl-2 and caspases, under 
combinational treatment of starvation and differentiation-inducing factor (DIF), cell death 
was observed with autophagic structures (Levraud et al., 2003; Roisin-Bouffay et al., 
2004), however, autophagy might not be the exact death mechanism as necrosis still 
existed when autophagy was abrogated by disrupting Atg1 (Kosta et al., 2004). Similarly, 
in Drosophila, although autophagy induction accelerated developmental degradation in 
salivary glands, inhibition of autophagy still caused a delayed histolysis (Berry and 
Baehrecke, 2007). Thus it is still not clear whether autophagy was the cell death 
executioner.   
 
1.1.4 Autophagy in health and disease 
 
Besides its function in normal physiological conditions, autophagy has been shown 
to possess diverse functions under pathological conditions and contribute to the 
pathogenesis of many diseases including cancer, neurodegenerative diseases, metabolic 
diseases, immunodeficiency diseases, and infectious disease. Figure 1.3 is a brief summary 
of the relationship between autophagy and human disease (Mizushima et al., 2008). 
For example, upregulation of autophagy has been proposed to be a useful 
therapeutic strategy for neurodegenerative disease treatment, based on the evidence that 
autophagy is the major clearance pathway for many neurodegenerative disease-associated 
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mutant proteins and the discovery that neurodegenerative diseases are promoted when 

















                 
 
 
                 Figure 1.3  The role of autophagy in human diseases  




           
          1.1.4.1 Autophagy in cancer 
 
   Being a multifaceleted process, the deregulation of autophagy is observed in a 
series of pathological conditions such as aging, infectious diseases, neurodegenerative 
diseases, metabolic diseases and most importantly, cancer. 
   However, autophagy's role in cancer is a little complicated, a fundamental paradox 
is that it has both positive and negative effects on tumorigenesis as autophagy can act to 
promote either cell survival or cell death depending on the specific conditions. 
 
          1.1.4.1.1 The anti-cancer function of autophagy 
             
   1.1.4.1.1.1 Evidence supporting the anti-cancer function of autophagy 
          
          Although autophagy might have dual roles in tumorigenesis, the balance has tilted 
more to the notion that autophagy is a tumor suppressive mechanism. Evidence includes:  
         (1).Several tumor cells have relative weak autophagic activity (Schwarze et al., 1985;     
Knecht et al., 1984).  
         (2). Atg genes are frequently observed to be deleted in various kinds of human 
malignancies (Levine, 2007a).  
         (3). Several Atg genes act as tumor suppressors. For example, loss of Beclin 1, which 
is frequently deleted in human breast, ovarian, and prostate cancer, increases 
tumorigenesis in mice and tumor growth is inhibited during Beclin 1 overexpression 
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(Liang et al., 1999; Qu et al., 2003; Yue et al., 2003); Atg4c has also been proved to be a 
tumor suppressor (Marino et al., 2007). Overexpression of Atg5 inhibits tumor growth and 
stimulates apoptosis (Yousefi et al., 2006).  
           (4). The upstream signaling pathways of autophagy include many oncogenes and 
tumor suppressor genes. Oncogenes like Class I PI3K, Akt or mTOR that inhibit 
autophagy are activated, while tumour suppressor genes like p53, PTEN, DAPK1, 
TSC1/TSC2, LKB1/STK11 that stimulate autophagy are mutated or epigenetically 
silenced in tumors (Botti et al., 2006).   
           (5). Autophagy contributes to the integrity of genome as immortalized epithelial 
cells with loss of Beclin 1 or Atg5, display increased DNA damage, gene amplification, 
and tumorigenicity (Mathew et al., 2007). 
 
          1.1.4.1.1.2 Possible mechanisms of the anti-cancer function of autophagy 
             
Autophagy, as a homeostatic process, removes toxic cellular compounds such as 
spent organelles, misfolded and aggregated proteins which can contributed to various 
stresses, can help to eliminate the cytotoxic microenvironment which will favor 
tumorigenesis (Wang et al., 2010).  In addition, autophagy helps to prevent the genome 
mutation and chronic tissue damage which are common causes for cancer development 
(Chen et al., 2011). 
Recent studies have revealed that p62, the selective autophagy substrate protein, 
might be a possible bridge linking autophagy to tumorigenesis.  Defective autophagy will 
leads to accumulation of p62 which will cause liver damage and facilitate the tumor 
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development in mice (Komatsu et al., 2007; Mathew et al., 2009a). Indeed, p62 
accumulation was proved to be able to abrogate NF-kB activation which will casue cell 
death and inflammation which will trigger tumorigenesis (Maeda et al., 2005). 
Additionally, p62 accumulation also activates the expression of transcription factor NF-
E2–related factor 2 (Nrf2) and its target genes whose constitutive activation are associated 
with increased cancer incidence (Komatsu et al., 2010; Lau et al., 2010; Kensler and 
Wakabayashi, 2010). 
          
           1.1.4.1.2 The pro-cancer function of autophagy  
 
On the other hand, autophagy can also favor tumorigenesis by preventing cells from 
cell death under nutrient deprivation and hypoxia. The protective effects of autophagy on 
tumor cell's resistance to chemotherapy were also reported (Abedin et al., 2007; Carew et 
al., 2007). For example, overexpression of the oncogenic Ras gene will result in 
tumorigenesis, interestingly, upregulation of Ras also dramatically upregulates basal 
autophagy which is esstential for cell survival under various stress conditions. In human 
cancer cells in which Ras is activated, genetic suppression of autophagy results in cell 
death or growth arrest (Guo et al., 2011; Lock et al., 2010; Yang et al., 2011). 
 
            1.1.4.1.3 Targeting autophagy as a novel cancer therapeutic strategy 
 
As basal autophagy is employed by many cancer cells as a protective mechanism 
against hostile microenvironment, once tumorigenesis is initiated, inhibiting autophagy 
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might be a novel therapeutic strategy to treat cancers (Chen et al., 2011). As mentioned 
above, suppression of autophagy in Ras-driven cancers decreases tumorigenesis, 
pharmacological inhibition of autophagy also sensitizes tumor cells to cell death. For 
instance, CDP, the autophagy late stage inhibitor, can kill Myc-expressing mouse cells in a 
p53-dependent manner (Maclean et al., 2008;  Amaravadi et al., 2007). It was proposed 
that cancer cells employ autophagy not only for releasing metabolic stress but also 
therapeutic stress. In this regard, many ongoing clinical trials use HCQ as an autophagy 
inhibitor for the treatment of a series of advanced diseases (Amaravadi et al., 2011; White 
and Dipaola, 2009). 
 
1.1.5 Methods for monitoring autophagy 
 
Being a dynamic, multi-stage process, autophagy can be monitored at various 
steps. During the past decade which witnessed the dramatic increase of  autophagy related 
research projects, a series of  related techiniques are established and well recorded in 
some reviews (Mizushima et al., 2010; Klionsky et al., 2007).  
Especially, regarding to the increased number of autophagosome – the most 
common marker of autophagy, the most critical issue is to distinguish the enhanced 
autophagic activity from blockage of late stage of autophagy. “Autophagic flux” assay 
which employs lysosome inhibitor to block the late stages of autophagy was proposed to 
solve this problem (Mizushima et al., 2010). For example, in the LC3 turnover assay, 
with introduction of lysosomal inhibitor CDP, the LC3-II degradation will be blocked, 
thus the difference in the amount of LC3-II between groups treated with or without CDP 
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represents the genuine amount of LC3-II that delivered to autolysosome for degradation. 
The starvation-induced difference between groups treated with or without CDP is larger 
than the difference between control groups (cultured in full medium) treated with or 
without CDP, indicating that autophagic flux  is increased under starvation treatment 
(Mizushima et al., 2010). 
So, a combination of approaches is suggested to be a better way to access the 
autophagic activity. Table 1.2 is the summary of the classical methods used for 
monitoring mammalian autophagy. 
 
             Table 1.2 Methods for monitoring mammalian autophagic activity 







organelles for execution of autophagy, both 
autophagosomes and autolyosomes are increased in 
numbers indicates autophagy activation and   an 
increased autophagosome numbers without a change 












LC3-Is a specific marker for autophagosome, upon 
lipidation, the cytosolic LC3-I will become LC3-II 
and translocate to the membranes of 
autophagosome. The differences in the amount of 
GFP-LC3-II puncta between samples in the 
presence and absence of lysosomal inhibitors reflect 
the autophagic activity. 
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in systems with both GFP-LC3 and RFP-LC3, 
GFP-LC3 will be degraded in autolysosome while 
RFP-LC3  is more stable, autophagosomes and 
autolysosomes are thus labeled with yellow (RFP 
and GFP) and red (RFP only), respectively. 
Both yellow and red puncta are increased indicates 
increased autophagic flux; only yellow puncta are 
increased without a concomitant increase in red 













cells are cultured with isotope-labeled amino acids to 
label long-lived proteins, followed by a short 
incubation period without isotope-labeled amino 
acids to labeled short-lived proteins.  the 
tricholoracetic acid-soluble radioactivity in the 
culture supernatant is from the degraded long-lived 








         In the past decades, interest in the detection and function of small RNA molecules 
has rapidly expanded, resulting into two hot research fields: small interfering RNAs 
(siRNAs), which can silence the expression of specific genes at the post-transcriptional 
level; and microRNAs (miRNAs), which have been shown to regulate various target gene 
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expression in many organisms. Both miRNAs and siRNAs are 18–30 nucleotides in length 
and their processing pathways have a lot in common (Zeng et al., 2003). 
miRNAs are a class of evolutionary conserved, small (18 to 25 nucleotides in length), 
endogenous non-coding RNA molecules which negatively regulate gene expression either 
by transcript degradation or translation repression at the transcriptional and post-
transcriptional level (Ambros, 2004). miRNAs play important roles in many processes 
such as development, cell proliferation, differentiation and death. They accomplish their 
roles by binding to the 3' untranslated region (3'-UTR) of target messenger RNA (mRNA), 
the regulatory results are depending on the degree of complementarity in base pairing.  
First discovered by Ambros and colleagues in 1993 in C.elegans (Lee et al., 1993; 
Wightman et al., 1993), miRNAs are shown to be abundantly expressed in viruses 
(Sullivan et al., 2006), plants (Mallory and Vaucheret, 2006) and animals (Stefani and 
Slack, 2008). To date, 16772 miRNAs have been found in 153 species (miRBase Release 
17, http://www.mirbase.org/ ). The sequence and function conservation of many miRNAs 
between distantly related organisms indicates that this class of small RNAs is an integral 
part of essential cellular processes (Pasquinelli et al.,  2000). Human beings are able to 
express about 1424 miRNAs (http://www.mirbase.org ).  These miRNAs are expected to 
be able to regulate more than 30% of all protein–coding genes (Filipowicz et al., 2008). 
 
          1.2.1  miRNA biogenesis 
 
Encoded in the genome, miRNAs are transcribed by RNA polymerase II as primary 
transcripts (pri-miRNAs) that are typically 3 to 4 kilobases long single-stranded RNAs 
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with 5’cap, 3’ poly(A) tail and complicated secondary structures (Lee et al., 2004; Saini et 
al., 2007). A microprocessor complex comprising the nuclear RNase III, Drosha, and the 
double-stranded RNA binding protein, Pasha/DGCR8 (Gregory et al., 2004; Han et al., 
2004) then processes the pri-miRNAs into one or more precursor-miRNAs (pre-miRNAs) 
of ~70-nucleotides. Pre-miRNAs are then actively exported to the cytoplasm through 
exportin-5 together with RAN-GTPase (Bohnsack et al., 2004; Yi et al., 2003), then 
another RNase III, Dicer, further processes them into ~22-nucleotide mature 
miRNAs,which are  double stranded (miR duplex). The miRNA strand in the miRNA 
duplex is incorporated into the multi-protein RNA-induced silencing complex (miRISC) 
whereas the other stand, the complementary strand (miR* strand) is degraded (Hutvagner 
et al., 2001; Ketting et al., 2001). Thermodynamic stability of the strand probably 
determines the choice of strands to be incorporated into miRISC (Khvorova  et al., 2003). 





         
                                                                                            
         Figure 1.4 miRNA biogenesis pathway  
          (adapted from Winter et al., Nature Cell Biology, 2009) 
 
1.2.2 Regulatory mechanisms of  miRNAs 
 
          miRNA and their target genes form a very complex regulatory network since each 
individual miRNA can potentially regulates hundreads of target genes (Lim et al., 2005), 
and each target gene can be cooperatively controled by a series of miRNAs (Lewis, 2003). 
          For each specific interaction, the seed region, an area on the mature miRNA which 
typically includes nucleotides 2-7 in the 5' end that binds to the 3' untranslated region (3' 
UTR) of the mRNA, plays a crucial role in determining the regulatory effect. miRNAs 
binding with imperfect complementarity to the  3'UTR of target mRNA usually repress the 
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translation of the target mRNAs while miRNAs with perfect complementarity can degrade 
the corresponding target mRNAs (Meister and Tuschl, 2004). 
To date, the mechanism by which miRNAs cause blockage of target gene translation 
is still not clear. However, a number of pathways that contribute to this process have been 
revealed. Wu et al. have found that most target mRNAs underwent deadenylation and 
subsequent destabilization (Wu et al., 2006). And specific miRNAs together with their 
target mRNAs have been found to be stored in the processing bodies (P bodies) which 
usually are the cytoplasmic storage sites for proteins involved in mRNA decay, 
translational repression and non-translating mRNAs (Chan and Slack, 2006). In addition, 
the argonaute family proteins, Ago2 has been detected in P bodies in a miRNA-dependent 
manner (Sen and Blau, 2005). Future investigations are required to elucidate this improtant 
gene regulation mechanism. 
 
1.2.3 Biological functions of miRNAs 
 
Cross-species comparisons demonstrate that miRNAs are evolutionarily conserved 
and play important roles in a wide array of physiological and pathological processes such 
as proliferation, apoptosis, differentiation, immunity and angiogenesis. Thus miRNAs are 
involved in a series of diseases including cancer, cardiac diseases, gastrointestinal diseases 
and diabetes (Huang et al., 2011).  
Evidences for the important roles of miRNAs in tumourigenesis including the 
following several aspects. About 50% of miRNA genes are in cancer-associated genomic 
regions (Calin et al., 2004; Sevignani et al., 2006). Deregulated miRNA expression 
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profiles are associated with many cancer types; more than one-quarter of all known human 
miRNAs are reported to be deregulated in at least one cancer type (Wang et al., 2009). 
miRNA expression profiling of specific cancer can be used to identify new biomarkers of 
tumor subtype. For example, miR-103/107 is important diagnostic and prognostic markers 
of esophageal cancer (Guo et al., 2008a). The expression of a subset of miRNAs (miR-21, 
miR-155, miR-181b, miR-221, miR-222) was found to be consistently up-regulated, 
whereas another subset of miRNAs (miR-143, miR-145, let-7/miR-98 cluster) was 
consistently down-regulated across different cancer types, suggesting their involvement in 
common cellular pathways whose deregulation may lead to tumourigenesis  (Wang et al., 
2009 ). Emerging evidences have demonstrated that these deregulations indeed implicate 
miRNAs’ roles in tumourigenesis, with the fact that those miRNAs commonly down-
regulated in cancers are often tumor suppressors while those commonly up-regulated are 
often oncogenes. What is more, overexpression or knockdown of some deregulated 
miRNAs would result in abnormal cell development.   
Of several miRNAs that are implicated in cell proliferation and apoptosis, some 
miRNAs, such as miR-29b and miR-15-16, influence only the apoptotic pathway, whereas 
others including let-7/miR-98 and miR-17-92 may play roles in both the apoptotic and 
cell-proliferation pathways (Secombe et al., 2004; Adhikary et al., 2005), indicating the 
complexity of the miRNA regulatory mechanism. Noticeably, even very similar, closely 
related miRNAs may have different impacts on oncogenesis. For example, miR-199a, was 
shown to target several oncogenes such as IKKbeta (Chen et al., 2008b), MET and ERK 
(Kim et al., 2008b); while miR-199b may play a house-keeping role and do not contribute 
to oncogenesis as it is seldom reported to be deregulated in cancer (Wang et al., 2009).  
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Although functional studies with relevance to cancer and cell death are still limited 
compared to the large amounts of miRNAs, dozens of cellular targets of miRNAs have 
been validated. In the tumor-suppressive miRNA group, for instance, let-7/miR-98 family 
negatively regulate HMGA2 (Peng et al., 2008), Ras (Johnson et al., 2005 ), IGF2BP1 (Lu 
et al., 2007), c-Myc (Sampson et al., 2007), NF2 (Meng et al., 2007a), LIN28B (Guo et al., 
2006) ,CDC25a, CDK6, Cyclin D, CCND2 (Johnson et al., 2005), and caspase-3 (Tsang 
and Kwok,  2008). miR-34a and miR-34b/c enhance p53 function by targeting signal 
molecules such as CDK4, E2F3, Bcl2, SIRT, N-Myc, c-Met, CDK6, and c-Myc 
(Hermeking, 2009). The miR-15-16 cluster target Bcl-2 (Cimmino et al., 2005) and NGN3 
(Joglekar et al., 2007); and miR-29b also negatively regulates Mcl-1 (Mott et al., 2007), a 
member of the Bcl-2 family. In contrast, oncogenic miRNAs also form their complex 
signal network, for example, miR-21 targets PTEN (Meng et al., 2007b), TPM1 (Zhu et al., 
2007), PDCD4 (Lu et al., 2008), MASPIN/SERPINB5 (Zhu et al., 2008), MARCKS (Li et 
al., 2009a), HNRPK (Papagiannakopoulos et al., 2008), and RECK (Zhang et al., 2008); 
miR-210 decreases caspase activation which leads to apoptosis (Kulshreshtha et al., 2007 ) 
and regulates EPHRIN-A3/EFNA3 (Fasanaro et al., 2008); while miR-155 inhibits 
TP53INP1 expression and thus reduces apoptosis (Gironella et al., 2007). In addition, 
E2F1 (Sylvestre et al., 2007), TSP1, CTGF (Dews et al., 2006), PTEN (Xiao et al., 2008 ), 
BIM, Rb2 (Wang et al., 2008a ), p21(Fontana et al., 2008) , AIB1 (Hossain et al., 2006 ), 
AML1, M-CSFR (Fontana et al., 2007) are regulated by miR-17-92 cluster. Interestingly, 
some miRNAs have dual roles in regulating both cell proliferation and apoptosis during 
cancer development. For instance, miR-224 was reported to sensitize cells to apoptosis 
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through the apoptosis inhibitor API-5, yet, it also increased cell proliferation (Wang et al., 
2008b). 
With the potential of being used as therapeutic drugs that prevent cancer by directly 
targeting oncogene transcripts, miRNAs are receiving more and more attention these years. 
 
1.2.4 Involvement of miRNAs in autophagy 
 
Despite the large amount of publication elucidating autophagy regulatory 
mechanisms, so far, research focusing on the relationship between autophagy regulatory 
elements and miRNAs, espeically Atg genes and miRNAs are still limited. And there is no 
publication directly elucidating the miRNA expression pattern during autophagy induction 
and execution. Hopefully, this area will gain more and more attention in the following 
years. 
 
1.2.4.1 miRNAs directly regulate Atg genes 
 
1.2.4.1.1 miRNAs target Beclin 1 
 
Zhu et al. demonstrated that Beclin 1, the mammalian homologue of yeast Atg6 was 
negatively regulated by miRNA-30a in human breast and lung cancer cells in which the 
Beclin 1 expression was usually deregulated. Tumor cells treated with the miR-30a mimic 
showed a decreased expression of Beclin 1 mRNA and protein, whereas tumor cells 
treated with the miR-30a antagomiR showed the opposite result. Through dual luciferase 
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reporter assay, they confirmed that the miR-30a binding sequence is in the 3’-UTR of 
Beclin 1. Inhibition of Beclin 1 expression by miR-30a mimic blunted activation of 
autophagy induced by Rapamycin (Zhu et al., 2009). 
 
1.2.4.1.2 miRNAs target LC3-II 
 
Recently, Xiao et al. found that during ischemia-reperfusion (IR) injury induced 
autophagy, miR-204 was downregulated while its target gene LC3-II was upregulated. 
Upon transfection of miR-204 mimic, LC3-II protein was attenuated while during AMO-
204 (miR-204 inhibitor) transfection, LC3-II protein was up-regulated. Interestingly, They 
found miR-204 only targeted LC3-II under such condition, LC3-I was not a target of miR-
204 (Xiao et al., 2011). 
 
1.2.4.1.3 miRNAs target Atg4d 
 
             Frankel et al. has proposed that miR-101, a tumor suppressive miRNA, is a potent 
inhibitor of basal, etoposide- and Rapamycin-induced autophagy, and this miRNA may 
execute its inhibitory function via suppressing multiple autophagy related target genes 
(Frankel et al., 2011). They conducted a functional screen for the miRNA regulators of the 
autophagic flux in breast cancer cells. Through transcriptome profiling analysis, they 
identified three autophagy related genes STMN1, Rab5a and Atg4d are targeted by miR-
101 under autophagic conditions. And this miR-101 mediated inhibition of autophagy can 
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sensitize cancer cells to 4-hydroxytamoxifen (4-OHT)-mediated cell death (Frankel et al., 
2011).  
 
1.2.4.2  miRNAs target upstream signal molecules that regulate autophagy 
 
          Besides the autophagic core machinery, various components in the upstream 
signaling pathways of autophagy have also been proved to be tightly regulated by a series 
of miRNAs. However, most of these studies haven’t further their functional studies into 
the autophagic field, so far it is still not very clear whether these miRNAs can affect 
autophagy in specific settings via corresponding suppression of their target genes. 
 
          1.2.4.2.1 Potential positive miRNA regulators of autophagy that target autophagy upstream 
           signaling network  
 
miRNAs have been proved to target a series of autophagy upstream signaling 
molecules which place unfavorable effects on autophagy induction and execution 
including mTOR, PI3K/Akt, Ras, ERK, Rb, and Bcl2. Table 1.3 summarize these miRNAs 
which have potential positive impact on autophagy. 
           Recently, several groups have discovered that mTOR, the key regulator of 
autophagy pathway is also under dynamic control of various miRNAs. Fornari et al. has 
discovered miR-199a-3p which is downregulated in several human cancers including HCC, 
targeted mTOR and c-Met in HCC cells (Fornari et al, 2010). Attenuating miR-199a-3p 
will enhance susceptibility of cell to hypoxia treatment, indicating autophagy’s 
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involvement. Similarly, Nagaraja et al. found that miR-100 which is the most 
downregulated miRNA in their clear cell ovarian cancer cell lines, targets FRAP1/mTOR 
(Nagaraja et al., 2009). Oneyama et al. has found that mTOR is a target of miR-99a which 
is downregulated upon c-Src activation. Overexpression of miR-99a downregulates mTOR 
and leads to suppression of tumor growth (Oneyama et al., 2011). 
Growth factors activate receptor tyrosine kinases (RTKs) which stimulate the 
phosphatidylinositol 3-kinases (PI3K), PI3K then activates mTOR for stimulating cell 
growth and inhibiting autophagy. miR-126 inhibits PI3K signaling as detected by reduced 
levels of phosphorylated Akt. The PI3K regulatory subunit p85β is a potential target of 
miR-126 (Guo et al., 2008b). Blockage of miR-205 by using a synthetic antagomiR, or by 
the ectopic expression of miR-184, leads to decreased phosphorylated Akt, phosphorylated 
BAD together with increased apoptosis (Yu et al., 2008). 
 The mammalian Ras proteins, H-Ras, K-Ras and N-Ras, modulate many 
proliferation pathways. Ras family also activate mTOR for inhibiting autophagy. Let-7 
family, composed of more than nine members, negatively regulates Ras proto-oncogene 
through multiple complementary sites in the 3’-UTRs of all three human Ras genes 
(Johnson et al, 2005).  miR-143 also negatively regulates Ras (Lin et al., 2009). 
ERK, a downstream signal of Ras, can inhibit autophagy by activating mTOR as 
well. ERK1/2 is reported to be a target of miR-199a (Kim et al., 2008b). miR-143 also 
targets ERK5 and thus suppresses cell growth and enhances CH-11-induced apoptosis 
(Akao et al., 2009). 
The retinoblastoma (Rb) tumor suppressor functions as a negative regulator of the 
cell cycle through inhibition of E2F transcription factors (Trimarchi and Lees, 2002). Loss 
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of pRb has been shown to sensitize tumor cells to apoptosis (Chau and Wang, 2003); and 
pRb attenuates the induction of BNIP3, a Bcl-2 superfamily member, by hypoxia-
inducible factor to prevent autophagic cell death (Tracy et al., 2007). miR-106-363 cluster 
(Landais et al., 2007) and miR-290 (Benetti et al., 2008) also target Rb. Epigenetic loss of 
miR-124a is correlated with activation of CDK6 and phosphorylation of Rb (Lujambio et 
al., 2007). 
  















miRNA Favorable Effect on Autophagy Reference 
miR-199a 
targets mTOR and c-Met as well as mTOR's 
activator ERK1/2 
(Fornari et al., 2010; Kim et al., 
2008b) 
miR-100 targets mTOR/FRAP1 (Nagaraja et al., 2009) 
miR-99a downregulates mTOR (Oneyama et al., 2011) 
miR-126 
inhibits PI3K signaling and decreasing 
phosphorylated Akt 
(Guo et al., 2008b) 
miR-184 decreases phosphorylated Akt (Yu et al., 2008) 
let-7 family 
targets mTOR activator - Ras proto-
oncogenes  
(Johnson et al, 2005) 
miR-143 targets Ras and ERK5 




targets Rb (Landais et al., 2007) 
miR-290 targets Rb (Benetti et al., 2008) 
miR-124a deactives phosphorylation of Rb (Lujambio et al., 2007) 
miR-15-16 
cluster  
targets Bcl-2 (Cimmino et al., 2005)   
miR-1 targets Bcl-2 (Tang et al., 2009) 
miR-29b targets Mcl-1 (Mott et al., 2007) 
miR-512 downregulates Mcl-1 (Saito et al., 2009) 
miR-101 targets Mcl-1 (Su et al., 2009) 
miR-153 downregulates Bcl-2 and Mcl-1 (Xu et al., 2010) 
miR-133b targets Mcl-1 and Bcl-W (Crawford et al., 2009) 
miR-122 targets Bcl-W (Lin et al., 2008) 
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Bcl-2 family contain both antiapoptotic and proapoptotic proteins. Bcl-2, Mcl-1, 
Bcl-xL, and Bcl-W are antiapoptotic proteins which can inhibit autophagy by binding to 
Beclin 1(Atg6) (Maiuri et al., 2007; Pattingre et al.,2005; Erlich et al., 2007). Several 
tumor suppressive miRNAs such as miR-15-16 cluster (Cimmino et al., 2005) regulate 
Bcl-2. miR-1 regulates cardiomyocyte apoptosis by targeting Bcl-2 (Tang et al., 2009). 
miR-29b increases cell apoptosis sensitivity to TRAIL by targeting Mcl-1, a member of 
the Bcl-2 family (Mott et al., 2007), but whether it can also lead to autophagy still needs to 
be examined. Epigenetic  activation of miR-512-5p induces suppression of Mcl-1, leading 
to apoptosis in gastric cancer cells (Saito et al., 2009). miR-101 also exerts its proapoptotic 
function via targeting Mcl-1 (Su et al.,2009). miR-153 downregulates both Bcl-2 and Mcl-
1 (Xu et al., 2010), while miR-133b targets Mcl-1 and Bcl-W (Crawford et al., 2009). 
miR-122 also targets Bcl-W (Lin et al., 2008).  
 
         1.2.4.2.2 Potential negative miRNA regulators of autophagy that target autophagy upstream 
         signaling network 
 
 Besides those potential positive miRNA regulators of autophagy, there are also 
miRNA counterparts which place unfavorable effect on autophagy via suppressing those 
autophagy-inducing upstream signaling molecules such as PTEN, E2F, FoxO1/3 and 
IRGM. These miRNAs are summarized in Table 1.4. 
The PTEN phosphatase is a dual-specificity protein and lipid phosphatase that 
counteracts PI3K activity and functions as a major tumor suppressor. miR-214 (Yang et al., 
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2008) and miR-21 (Meng et al., 2007b) were proved to inhibit PTEN expression in human 
cancer, resulting in tumor cell proliferation, migration and invasion. 
 The E2F family play a crucial role in controlling cell cycle and actions of tumor 
suppressor proteins. In autophagy, the E2F family upregulate four autophagy genes: LC3, 
Atg1, Atg5 and DRAM (Polager et al., 2008). Several miRNAs such as miR-210 
(Giannakakis et al., 2008), miR-106b and miR-93 (Petrocca et al., 2008) are able to 
regulate E2F1-3. In prostate cancer cells, E2F1 is negatively regulated by miR-330 which 
induces apoptosis through E2F1-mediated suppression of Akt phosphorylation (Lee et al., 
2009).  
IRGM1 is essential to promote autophagy that kills bacteria. Recently, in the 
inflammatory intestinal epithelia of individuals with Crohn's disease, Brest et al. found the 
overexpressed  miR-196 downregulated the IRGM protective variant (c.313C) but not the 
risk-associated allele (c.313T). This effect affected autophagy's efficiency and 
subsequently compromised autophagy's control of replication of Crohn's disease-
associated adherent invasive Escherichia coli (Brest et al., 2011). 
The FoxO1 transcription factor, a putative tumor suppressor, regulates genes 
involved in the apoptotic response, cell cycle checkpoints, and other cellular metabolisms. 
Overexpression of either FoxO1 or FoxO3 results in decreased cell viability and enhanced 
expression of autophagy pathway genes. miR-27a, miR-96, and miR-182 were reported to 
cooperately down regulate FoxO1 in breast cancer cells (Guttilla et al., 2009). 
Overexpression of miR-182 promotes melanoma metastasis by repressing FoxO3 and 
microphthalmia-associated transcription factor (Segura et al., 2009). 
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Additionaly, the  miR-146a mimic upregulates Bcl-xL and STAT3 phosphorylation 
(Liu et al., 2009). miRNAs also regulate proapoptotic Bcl-2 family members such as BIM. 
For example, miR-32 (Ambs et al., 2008) targets BIM. 
 










1.2.4.2.3 Potential miRNA regulators of autophagy that have dual function 
 
p53, a transcription factor encoded by the TP53 gene, regulates cell cycle and thus 
functions as a tumor suppressor. p53 can transactivate an autophagy-inducing gene, 
DRAM, which codes for a lysosomal protein (Crighton et al., 2006). p53-dependent 
induction of autophagy has been identified in response to DNA damage (Feng et al., 2005), 
Arf activation (Abida and Gu, 2008), or reexpression of p53 in p53-deficient tumor cells 
(Amaravadi et al., 2007). Inactivation of p53 by deletion, depletion or inhibition also 
triggers autophagy (TasdemiR et al., 2008). miR-34a, miR-34b/c, miR-26a, miR-182, are 
miRNA Unfavorable Effect on Autophagy Reference 
miR-214 inhibits PTEN (Yang et al., 2008) 
miR-21 inhibits PTEN (Meng et al., 2007b) 
miR-210 targets E2F1-3 (Giannakakis et al., 2008) 
miR-25-106b 
cluster 
targets E2F1-3 (Petrocca et al., 2008)  
miR-330 downregulates E2F1 (Lee et al., 2009) 
miR-27a downregulates FoxO1 (Guttilla et al., 2009) 
miR-96 downregulates FoxO1 (Guttilla et al., 2009) 
miR-182 downregulates FoxO1 and FoxO3 
(Guttilla et al., 2009, Segura et 
al., 2009) 
miR-196 targets IRGM1(c.313C) (Brest et al., 2011) 
miR-146a 
upregulates Bcl-xL and STAT3 
phosphorylation 
(Liu et al., 2009) 
miR-32 targets BIM (Ambs et al., 2008) 
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consistently induced after p53 activation, indicating they may serve as direct p53 targets. 
miR-34 family also increase p53-mediated apoptotic sensitivity (Chang et al., 2007b). 
miR-192 and miR-215, which can impact cell proliferation, are directly regulated by p53 
( Song et al., 2008). miR-372 and miR-373 inhibit p53 directed CDK signaling, promoting 
tumorigenesis in testicular germ cells by targeting LATS2 (Voorhoeve et al., 2006). In 
addition, loss of miR-122 is suggested to facilitate genomic instability due to the lack of 
translational repression of the p53 inducible CCNG1 (Gramantieri et al., 2007). Recently, 
miR-125b and miR-504 are identified as novel negative regulators of p53 (Le et al., 2009; 
Hu et al., 2010 ). miR-127 may increase TP53-dependent apoptosis by disrupting the 
negative regulatory feedback loop between Bcl-6 and TP53 (Saito et al., 2006), whereas 
miR-155 inhibits TP53INP1-mediated apoptosis by directly targets TP53INP1 (Gironella 
et al., 2007). 
miR-17-92 cluster also have dual functions in regulating autophagy upstream 
signaling network.  On one hand, miR-17-92 place favorable effect on autophagy. miR-17-
92 cluster was reported to activate the cyclinD1/CDK4 complex to release Rb's inhibition 
on E2F and downregulate Rb directly to drive cell proliferation (Wang et al., 2008a). 
Meenhuis et al. also identified sequestosome 1 (SQSTM1), a  regulator of autophagy-
mediated protein degradation, as a major target of miR-17 family in myeloid progenitors 
and mature neutrophils (Meenhuis et al., 2011). On the other hand, miR-17-92 cluster was 
proved to inhibit PTEN (Xiao et al., 2008), E2F1-3 (Sylvestre et al., 2007) as well as the 
proapoptotic Bcl-2 family member BIM (Xiao et al., 2008). 
Similarly, miR-34 also has ability to influence both signals that favor autophagy and 
disfavor autophagy. Bcl-2, the inhibitor of Beclin-1, was proved to be a target of miR-34a 
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(Bommer et al., 2007). However, miR-34 can also directly target E2F1-3 (Tazawa et al., 
2007). 
 
 1.3  Objectives of the study 
 
Generally, the regulatory role of miRNAs in autophagy has not been systematically 
studied. At the time when this project started, Beclin 1 is the only Atg gene that was 
reported to be regulated by miRNA, although a series of research found that miRNA target 
genes involved in the upstream regulatory network of autophagy, most of these projects 
extend their functional studies into the autophagy field. Thus, we want to establish the role 
of miRNAs in autophagy regulation and function, the hypothesis is that miRNAs are 
capable of modulating autophagy via targeting the autophagy machinery (Atg genes), or 
the upstream signaling molecules, and subsequently affect the efficiency of autophagy. 
We aim to: 
1. Identify and confirm candidate miRNAs that are differentially expressed during 
autophagy induction. 
2. Characterize the target genes of the deregulated miRNAs that involved either in 
the autophagy machinery or the autophagy upstream regulatory pathways. 
Results from this study will advance the current understanding of the regulatory 
mechanisms of autophagy as well as expand the functional scope of miRNAs. We also 
hope the findings from this study will contribute to the development of novel therapeutic 





























Chapter 2   Materials and Methods 
  
2.1     Materials and reagents 
 
 Taqman miRNA individual assays were purchased from Applied Biosystems, The 
negative control miRNA, mimic and antagomir of mmu-miR-93 were purchased from 
Ambion. Rapamycin, earles’s balanced salt solution (EBSS), and chloroquine were 
purchased from Sigma-Aldrich. Primers were purchased from 1
st
 BASE Pte Ltd. SacII 
restriction endonucleases was purchase from New England Biolab (NEB).The pAPI5-
3UTR-WT plasmid was a kind gift from Dr. Wang Yu and A/Prof. Caroline Lee Guat Lay. 
 
2.2     Cell culture 
 
Atg5 WT, Atg5-/- MEF and GFP-LC3 MEF(Tet-off Atg5 MEFs) cell lines were 
obtained from Prof. Noboru Mizushima, these cell lines are maintained in Dulbecco’s 
modified Eagle’s medium (Sigma) containing 10% fetal bovine serum (FBS, from 
HyClone, Logan,UT, USA) and 1% penicillin-streptomycin (Invitrogen, Carlsbad, CA, 
USA) in a 5 % CO2 atmosphere at 37°C. For starvation, cells are cultured in EBSS (Sigma-
Aldrich, St. Louis, USA). 
 




 miRNA expression analysis was conducted using the miRXplore
TM
 Microarrays in 
the Lab of Miltenyi Biotec microarry servicing facility in Germany. 
Total RNA Samples including low molecular weight RNAs were first checked for 
quality using the Agilent 2100 Bioanalyzer platform (Agilent Technologies). RNA 
Intergrity Number (RIN) was calculated for each sample. All samples revealed RIN values 
between 9.5 and 10 which indicate the samples are highly processable. The treatment 
groups were labeled with Hy5 (Red) and the control groups were labeled with Hy3 (Green) 
according to the undisclosed miRXplore
TM
 user manual. Then the fluorescently labeled 
samples were hybridized overnight to miRXplore
TM
 Microarrays using  a-Hyb
TM
 
hybridization station. Fluorescence signals were detected using an Agilent laser scanner. 
Mean signal and mean local background intensities were obtained for each spot of the 
microarray images using the ImaGenea software (Biodiscovery). Low quality spots were 
flagged and excluded from data analysis. Unflagged spots were analysed with the 
PIQOR
TM
 Analyzer software. After normalization and another quality control step which 
only took into account those spots with the Hy5/Hy3 ratio from signal that was equal or 
higher than 50% of the background signal intensities, the Significance Analysis of 
microarrays (SAM) was then used to identify miRNAs that displayed significant 
expression difference between the treatment groups and the control groups. The miRNAs 
were identified at a false discovery rate of less than 0.05 and an absolute SAM score of 
more than 2.5. 
 




Generally, prediction for target genes of a specific miRNA or prediction for miRNA 
regulator of a particular gene was first carried out using a combination of 11 prediction 
programs including DIANA-microT, MicroInspector, miRanda, MirTarget2, miTarget. 
Some of the 11 prediction programs were further checked for more specific purposes such 
as binding site conserveness among different species. 
 
2.5     MicroRNA isolation  
 
Total RNA or RNA enriched for small species was extracted with the mirVana™ 
miRNA Isolation Kit (Ambion) following manufacturer's instructions. 5x 10
5
 cells were 
freshly prepared, first lysed in 500 ul  lysis buffer and 50 ul miRNA homogenate addictive, 
incubated on ice for 10 minutes. Then 500 ul Acid-Phenol: Chloroform was added to the 
lysate, after centrifugation at 10,000 x g for 5 minutes, the upper phase was removed and 
added with 625 ul 100% ethanol, and then the lysate was passed through a collection 
column. The column was washed once with 600 ul wash buffer 1, twice with 500 ul wash 
buffer 2/3 and once with 700 ul 80% ethanol and centrifuged briefly at 10,000 x g. After 
that, the columns were centrifuged at the maximum speed for another minute to remove the 
residue, the total RNA or RNA enriched for small species was then eluted by 50 ul 
nuclease free water preheated at 99°C. 
 




         For the analysis of miRNA differential expression, Taqman MicroRNA Individual 
Assays (Applied Biosystems) were employed for validation. Each sample was analyzed in 
triplicates. Reverse transcription was carried out with 75 ng template RNA enriched for 
small species using Iscript TM cDNA Synthesis Kit (Bio-Rad) and miRNA specific reverse 
transcription primers. Real-Time PCR was performed in a 10 ul reaction mix comprising 
2ul 2X diluted reverse transcription product, 5 ul Taqman 2X Universal PCR Master Mix 
without UNG Amperase (Applied Biosystems), 2ul miRNA specific probes  and 1ul 
nuclease free water, on a Bio-Rad CFX96™ Real-Time PCR Detection System, with an 
initial denaturation step at 95 °C for 10 minutes, followed by 40 cycles of  95 °C for 15 
seconds and 60 °C for 1 minute. Fluorescence signal was measured at each extension step. 
The Taqman microRNA individual assays used in this study are listed in Table 2.1 
 
Table 2.1 List of Taqman microRNA individual assay used in Real Time qRT-PCR 
miRNA ID Mature Sequence( 5'- 3') Assay No. 
mmu-miR-93 CAAAGUGCUGUUCGUGCAGGUAG 001090 
mmu-miR-221 AGCUACAUUGUCUGCUGGGUUU 001134 
mmu-miR-181a AACAUUCAACGCUGUCGGUGAGU 000480 
mmu-let-7b UGAGGUAGUAGGUUGUGUGGUU 002619 
mmu-miR-21 UAGCUUAUCAGACUGAUGUUGA 000397 
mmu-miR-30c UGUAAACAUCCUACACUCUCAGC 000419 
mmu-miR-99a AACCCGUAGAUCCGAUCUUGUG 000435 
mmu-miR-34a UGGCAGUGUCUUAGCUGGUUGU 000426 
mmu-miR-17 CAAAGUGCUUACAGUGCAGGUAG 002308 
mmu-miR-199a CCCAGUGUUCAGACUACCUGUUC 000498 
 
For the analysis of autophagy transcripts levels, total RNA was extracted with the 
RNeasy kit (Qiagen). One microgram of total RNA from each sample was used as a 
template for cDNA synthesis using Iscript
TM
  cDNA Synthesis Kit (Bio-Rad) according to 
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the manufacturer’s protocol.  Real Time PCR was performed on the Bio-Rad CFX96™ 
Real-Time PCR Detection System using Bio-Rad Ssofast
TM
 EvaGreen Supermix. 
Amplification reaction mix included cDNA template corresponding to 50 ng total RNA, 
target gene primers (0.25 um), and 2X PCR Master Mix in a total volume of  20 ul.  
Amplification conditions included an initial denaturation step at 95 °C for 1  minute, 
followed by 40  cycles of denaturation at 95°C for 5 seconds, annealing at specific 
annealing temperature for 5 second and extension at 60  °C for 5 seconds. The green 
fluorescence was measured at each extension step. The specific primer sequences for each 
target gene examined are listed in Table 2.2. 
 
Table 2.2 List of primers for target genes of mmu-miR-93 used in Real Time qRT-
PCR 























 The transcript expression was recorded as threshold cycle (CT) -  the fractional 
cycle No. at which the fluorescence signal exceeded a standard threshold, and relative 
54 
 
quantitation of gene expression was calculated by the △△CT method (Livak et al, 2001). 




2.7     Transfection  
 
Atg5 WT MEF and GFP-LC3 MEF cells were seeded 12-24 hour before the transient 
transfection in antibiotics-free medium and 20~30% confluency was achieved at the point 
of transfection. The transient transfection of miRNA negative control, mimic and 
antagomir were performed using Lipofectamine Plus reagents (Invitrogen) according to the 
manufacturer’s protocol. All transfected cells were harvested within 72 hours post 
transfection for further analysis. The short oligos used in transfection are listed in Table 2.3. 
                  
         Table 2.3 List of short oligos used in transient transfection 
Oligo Name Commercial Name Catalogue No. 
Pre-mmu-miR-93 Ambion Pre-miR miRNA Precursors PM10951 
Anti-mmu-miR-93 Ambion Anti-miR miRNA Inhibitors AM10951 
Negative control miR 
Pre-miR miRNA Precursor Molecules 




2.8     Western blot 
 
 After the designated treatments, whole cell lysates was prepared in M2 lysis buffer 
(20 mM Tris at pH 7, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM 
dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 20 mM glycerol 
phosphate, 1 mM sodium vanadate and 1X proteinase inhibitor cocktail). Insoluble 
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fractions were discarded after centrifugation at 15,000 g for 15 min. Protein was quantified 
using UV-2401PC. An equal amount of protein was resolved and loaded into 10~12% 
SDS-PAGE gel in the Mini-PROTEAN II system (Bio-Rad) and transferred onto PVDF 
membrane (Bio-Rad). After blocking with starting block (Thermo Scientific) for half an 
hour, the membrane was probed with designated first followed by corresponding second 
antibodies, developed with the enhanced chemiluminescence method (Pierce) and 
visualized with the Kodak Image Station 4000R (Kodak).  The major antibodies used in 
this study are listed in Table 2.4. 
 
 
          Table 2.4 List of major antibodies used in western blot 
Primary 
Antibody 




LC3B Rabbit polyclonal Sigma L7543 1:1000 16, 18kDa 








Atg7 Rabbit polyclonal ProSci 3617 1:1000 80kDa 
Ulk1 Rabbit polyclonal Sigma A7481 1:1000 150kDa 
STAT3 Rabbit polyclonal 
Cell 
signaling 
#9132 1:1000 79, 86kDa 




15 to 20 
kDa 
pS6 Rabbit polyclonal 
Cell 
signaling 
#2211 1:1000 32kDa 
GFP Mouse monoclonal Covance MMS-118R 1:1000 27kDa 
α-tubulin Mouse monoclonal Sigma T6199 1:2000 50kDa 
β-actin Mouse monoclonal Sigma A5316 1:2000 43kDa 




Secondary Antibody Source Company Catalogue No. Dilution Factor 
anti-Mouse Goat  Thermo Scientific #31430 3.513889 
anti-Rabbit Goat  Thermo Scientific #31460 3.513889 
 
 
9     Confocal microscopy 
 
The GFP-LC3 MEF cells were seeded to a 4 well or 8 well coverglass slide chamber 
(Lab-Tek®, NUNC), maintained in full medium for 16 hours before treatment. After 
designated treatments, the cells were then examined under confocal microscope Olympus 
Fluoview FV1000 (Olympus). 
 
 2.10   Generation of 3’ UTR reporter constructs 
            
The 1683 base pair of wild type Ulk1  3’ UTR was amplified from mouse genomic 
DNA and cloned downstream of a β-Galactosidase reporter gene driven by multidrug 
resistance associated gene (MRP1) promoter at the SacII restriction site. The human MRP1 
promoter was chosen over the human cytomegalovirus (CMV) promoter, because the 
MRP1 promoter is around 30 times weaker than the CMV promoter which will facilitate 
the measurement of subtle changes in the reporter gene activity. The reporter construct also 
carried a CMV promoter driven enhanced green fluorescence protein (EGFP) to normalize 
for differences in transfection efficiencies. A mutant reporter vector which include the two 
putative mutated miR-93 binding sites was also generated by PCR mutagenesis. The 
recombinant reporter vector carrying the widetype Ulk1 3’ UTR was termed as pUlk1-
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3UTR-WT while the mutant one was termed as  pUlk1-3UTR-MUT. The mutant site was 
verified in silico using PITA. Both constructs were verified by sequencing. Figure 2.1 
shows the cloning strategies and results. Primers used for PCR mutagenesis and sequencing 
are listed in Table 2.5 and Table 2.6. 
           















         Figure  2.1  Generation of Ulk 1 3’UTR reporter constructs. (A)Strategy for  
         PCR  mutagenesis at the two miR-93 binding sites of Ulk1 3’UTR. (B) Product of the  








         Table 2.5 List of primers for PCR mutagenesis 
 
Primer Sequence (5'~3') 
Primer 1   GCCTGACCGCGGCTACCTGCTGCCAACCTGCAGGG 
Primer 2  TCTGT ATGCA TGGGGGGA TCCGG TGACT TACAA AGCTG 
Primer 3    AGTCA CCGGA TCCCCCCA TGCAT ACAGA GACTG GAGAA 
Primer 4  ATCTT AGGAG TGAGGGG TGGAA GTTGA GGAGT TTTAA  
Primer 5  TCAAC TTCCA CCCCTCA CTCCT AAGAT GTGTC TCCAC 
Primer 6  CACATACCGCGGCAATAATTCCAATTTTTATTTTCTTAA 
 
 
       Table 2.6 List of primers for sequencing 
 
Primer Sequence (5'~3') 
POSITION 400 FORWARD GAAAAAAGGGTATGGTCTTCTGGCCCC 
POSITION 850 FORWARD  GAAAGGGCGGAGGCAGGGCAGGCC 
POSITION 1300 REVERSE TTCAAGTATTGCAAAGAAAAACG  
 
 
2.11   ß-gal reporter gene assay 
 
Atg5 WT MEF cells cultured in 6 well plates were transfected with either 1.0 ug of 
the pUlk1-3UTR-WT or the corresponding pUlk1-3UTR-MUT and co-transfected with 





 Amine Transfection Agent (Ambion) according to the manufacturer’s 
instruction. β-Galactosidase reporter gene activity was assayed kinetically using 
chlorophenol red-β-D-galactopyranoside (CPRG) as substrate and measured at 1 minute 
intervals over 60 minute at 570 nm in a SpectraMAX PLUS microplate reader (Molecular 
Devices, Sunnyvale, California, USA), with crude lysate from the transfected cells 




2.12   Statistical analysis 
 
All numerical data were presented as mean ± Standard Error of at least three 
independent experiments. Statistical significance was estimated with student’s t-test (two-
tailed distribution, two-sample equal variance). A p-value less than 0.05 was considered 












































Chapter 3   Results 
 
3.1  Identification of potential miRNA regulators in starvation-induced autophagy   
 
3.1.1 miRNA expression profiling of starvation induced autophagy 
          
 As mentioned in section 1.1.2, autophagy can be induced under a series of stress 
conditions in various cell types. To identify deregulated miRNAs in autophagy induction, 
we examined  the expression of 634 mouse mature miRNAs in Atg5 WT MEF cells versus 
Atg5 KO MEF cells with or without starvation treatment for 6 hours using miRXplore
TM 
miRNA microarrays (Figure 3.1 A, B). Starvation (EBSS) was selected as the initial 
cellular stress since amino acid deprivation is a well-established inducer of autophagy 
(Mizushima et al., 2010), EBSS treatment for 6 hours can efficiently induce autophagy in 
autophagy efficient MEF cell lines as evident from the conversion of LC3-I to LC3-II 
(Figure 3.1 C). The Atg5 WT and KO MEF cells were chosen as they were among the most 
popular cell line models for the current autophagy research. 
         Of these 634 mouse miRNAs, 541 miRNAs were not expressed in these four samples. 
The remaining 93 miRNAs were included in the subsequent analysis, and only 36 of them 
were significantly deregulated in at least one sample. The selection criteria was that in 
comparison with the control sample, only miRNAs that were upregulated or downregulated 
over 1.5 fold were considered to be significantly deregulated. However, as the microarray 
was done only once for each comparison, the results could not be statistically significant. 
Table 3.1 summarized the experiment design and results.         
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Figure 3.1 The miRNA microarray for miRNA expression profiling of starvation 
induced autophagy. (A) Hy5/Hy3 false-color image after scanning of the three 
microarrays. Red spot indicates the corresponding miRNA is overexpressed in the 
treatment group, green spot indicates the corresponding miRNA is downregulated, yellow 
spot indicates no deregulation. (B) Gel image indicates RNA qualities of the samples. The 
lowest green band represents an internal standard, the two prominent bands are 18S RNA 
and 28S RNA respectively. (C) Autophagy is induced in Atg5 WT MEF cell following 6 h 
EBSS treatment while there is no autophagy induction in Atg5 KO MEF cell which 












Table 3.1 Experiment design and result of the microRNA microarray 
*
 
          *Generally, four total RNA samples were prepared accordingly and three comparisons  
          were conducted, Atg5 WT1 and KO1 were samples cultured in full medium while  
          Atg5 WT2 and KO2 received a EBSS treatment for 6 h.  
 
The three microarray experiments revealed the clues of a general miRNA expression 
pattern when MEF cell were under EBSS condition for 6 hours: (1). miRNA induced by 
starvation (autophagy inducer) in both Atg5 WT and Atg5 KO MEFs: miR-30e, miR-689, 
miR-26b, miR-1902; (2). miRNA induced by starvation only in Atg5 WT MEFs: miR-93, 


















Atg5 WT1 Atg5 KO1 miR-152, miR-15a, miR-
181a, miR-18a, miR-21, 
miR-25, miR-30a, miR-
30b, miR-30c, miR-30d, 








EBSS Atg5 WT1 Atg5 WT2 miR-1902, miR-762, miR-





7180041 EBSS EBSS Atg5 WT2 Atg5 KO2 miR-26b, miR-17, miR-
1902, miR-34a, miR-30e, 
miR-222, miR-689, miR-
350, miR-487b, miR-28-
5p, miR-19a, Let-7f, miR-
322-miR-424, miR-m23-1-





MEFs: miR-322-miR-424; (4). miRNA reduced by starvation only in Atg5 WT MEFs: 
miR-221; (5). miRNA reduced by starvation only in Atg5 KO MEFs: miR-99a; (6). 
miRNA enhanced by Atg5 deletion (regardless whether starvation or non-starvation): miR-
34a, miR-467a-miR-467b, let-7f; (7). miRNA decreased by Atg5 deletion: let-7b, let-7c.  
Table 3.2 summarized these potential significantly deregulated miRNAs revealed by 
the microarray experiments. As shown in Table 3.2, we observed many of those  
deregulated miRNAs were clustered and associated either with functional family (let-7 
family, miR-17 family, miR-221 family, miR-30 family) or genomic loci (let-7 family on 
chromosome 15, miR-17 cluster on chromosome 14). And these miRNAs were found to be 
slightly enriched in chromosome 1, 14, 15, and X.  Interestingly, when compared with 
Atg5 WT and Atg5 KO cells, let-7f was significantly upregulated while another two 
members of the let-7 family, let-7b and let-7c were downregulated. This seems to be 
chromosome dependent, yet may also indicates that even being in the same functional 
family, these three miRNAs might have different major targets or there exists a 
homeostatsis for let-7 family. 










         Table 3.2 Significantly deregulated miRNAs in the microarray 
miRNA  Genomic Loci Genomic Cluster 
Functional 
Family 












2.96 1.18 1.61 
MMU-LET-7B chromosome: 15 Let-7c/Let-7b 0.61 1.10 0.62 
MMU-LET-7C chromosome: 15 Let-7c/Let-7b 0.60 0.97 0.62 
MMU-MIR-152 chromosome: 11  
miR-148 
family 2.58 1.10 1.36 
MMU-MIR-15A chromosome: 14 miR-15a/16 miR-15 family 1.68 1.24 1.21 
MMU-MIR-







family  1.01 1.63 
MMU-MIR-25 chromosome: 5 miR-93/25/106b 
miR-17 family 
2.22 0.96 0.85 
MMU-MIR-18A chromosome: 14 
miR-
17/18a/19a/20a/19b
/92a 1.56  1.06 
MMU-MIR-20A chromosome: 14 
miR-
17/18a/19a/20a/19b
/92a 1.53 0.73 1.31 
MMU-MIR-17 chromosome: 14 
miR-
17/18a/19a/20a/19b
/92a 1.19 1.13 1.53 
MMU-MIR-93 chromosome: 5 miR-93/25/106b 1.01 1.89 1.10 
MMU-MIR-
181A chromosome: 1 miR-181a/181b 
miR-181 
family 1.86 2.03 2.14 
MMU-MIR-19A chromosome: 14 
miR-
17/18a/19a/20a/19b
/92a miR-19 family  0.82 2.41 
MMU-MIR-
1902 chromosome: 2  
miR-1902 
family  1.55 2.05 
MMU-MIR-21 chromosome: 11  miR-21 family 1.72 1.05 1.04 
MMU-MIR-221 chromosome: X miR-221/222 miR-221 
family 
0.98 0.65 0.91 
MMU-MIR-222 chromosome: X miR-221/222 0.97 1.18 2.46 
MMU-MIR-26B chromosome: 1  miR-26 family  2.05 1.97 
MMU-MIR-151 chromosome: 15  
miR-28 family 
1.54  1.35 
MMU-MIR-28 chromosome 16  1.04  1.54 
MMU-MIR-30C chromosome: 4 miR-30c/30e 
miR-30 family 
2.53 1.15 1.13 
MMU-MIR-30A chromosome: 1  2.25 1.20 1.24 
MMU-MIR-30B chromosome: 15 miR-30b/30d 1.74 1.05 0.85 
MMU-MIR-30D chromosome: 15 miR-30b/30d 1.61 1.03 1.06 
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MMU-MIR-30E chromosome: 4 miR-30e/30c 1.20 2.13 3.58 





family   4.19 
MMU-MIR-34A chromosome: 4  miR-34 family 4.67  2.04 
MMU-MIR-350 chromosome: 1  
miR-350 
family 1.11 1.01 1.56 





family 1.62  1.24 










family 1.68 1.03 1.75 





family 2.02  1.39 
MMU-MIR-711 chromosome: 9  
miR-711 
family  1.66 0.91 
MMU-MIR-762 chromosome: 7  
miR-762 
family  1.89 1.33 
MMU-MIR-99A chromosome: 16 miR-99a/Let-7c miR-99 family 0.88 0.89 0.63 
MMU-MIR-689   
a fragment of 
rRNA  1.90 1.99 
MMU-MIR-
1274A   
a fragment of 
a Lys tRNA 1.59 1.53 1.87 
                *. 7180039, 7180040, 7180041 are  the miRNA microarray No. (Table 3.1). 
 
3.1.2    Target prediction of deregulated miRNAs 
  
In order to investigate the potential regulatory effect miRNAs may have on 
autophagy, a screen for the potential miRNA regulators was first conducted in silico with 
the expectation that those commonly up-regulated miRNAs in autophagy-deficient cell are 
often autophagy suppressors and those commonly down-regulated miRNAs are often 
autophagy inducers, using a combination of 11 miRNA-target prediction programs 
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(DIANA-microT, MicroInspector, miRanda, MirTarget2, miTarget, NBmiRTar, PicTar, 
PITA, RNA22, RNAhybrid, and TargetScan /TargertScanS). Most of these programs 
predict the target relationship based on the complementarity between the miRNA sequence 
and mRNA 3’UTR sequence, with additional selection criteria such as complete pairing at 
seed region, optimal thermodynamic stability, evolutionary conservation, and multiple 
target sites for the specific mRNA. 
As depicted in Figure 3.2, the strategy used was that, on one hand, a search was 
started from the deregulated miRNAs, aiming to find their predicted targeted autophagy 
related genes and autophagy upstream regulators; on the other hand, we also conducted a 
search for the potential miRNA regulators of the genes involved in the autophagy core 
machinery (a prediction was considered valid only if the target relationship was predicted 
by at least 3 programs). We gathered prediction results from both directions and selected 




                    Figure 3.2  Strategy of screening possible  miRNAs. 
 
After searching, the interested miRNAs were reselected based on the number of 
autophagy related genes they target and the importance of their target genes in autophagy. 
The top 10 interested miRNA are listed below: miR-93, miR-221, miR-181a, let-7b, miR-
21, miR-30c, miR-99a, miR-34a, miR-17, miR-199a. Table 3.3 summarizes the prediction 
results of these interested 10 miRNAs. The 10 miRNAs were also selected for further  

















































miR-34a has been demonstrated 
to be a target of p53, and function 
as a tumor suppressor. It targets 
E2F family and SIRT1, and is 
predicted to target Atg9b, Atg9a; 
however, it may also target Bcl2, 
Akt1 and Ras family member. 
When it downregulates E2F 
family members, it also 
upregulates p53 signaling 
pathway in human colon cancer 
cell lines, thus it may also have 



























miR-181a is predicted to target 
E2F, SIRT1,PTEN and ATG5, so 
it may block autophagy, however, 
it may also target BCL2 and 
Akt3. And it is upregulated in all 





in Atg5 KO 
cells, miR-





















miR-30c may block autophagy by 
targeting Atg genes such as Atg5, 
Atg12. It is also predicted to 
target the upstream signaling 
molecules such as SIRT1, Arf4. 
miR-30c may also block 

































miR-21 may block autophagy as 
it targets PTEN,Eif2, 
eif2ak4,E2F2 and leds to 
upregulation of PI3K/pAkt, but it 




























miR-221 may block autophagy by 
downregulating p27, 
Bcl2l11(Bim), but it may also 













































Let 7 family is a famous tumor 
suppressive miRNA family. It 
may  induce autophagy, because 
it inhibits Ras and its expression 
pattern. But it may also decrease 
autophagy by inhibitting TSC1 
and E2F family.  
miR-17 
upregulated 




















miR-17 may block autophagy by 
targeting Ulk1, Atg7, Atg16l1 as 
well as FOXO1, however, it may 
also place favorable effect on 
autophagy by targeting molecules 







































miR-99a may induce autophagy 
by directly targeting mTOR, 
although it may also have some 



























miR-199a may inhibit autophagy 
by targeting ERK, SIRT1, 
































miR-93 may inhibit autophagy by 
targeting Atg genes as well as its 
upstream signals. 
 
3.2    Validation of differentially expressed miRNAs in autophagy induction         
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To confirm the deregulated miRNAs’ expression is indeed due to autophagy 
induction, Taqman miRNA individual assays were employed to validate the miRNA 
expression level in Atg5 WT MEF and GFP-LC3 MEF cells. 
Since the Atg5 KO cell line was not generated from the paired Atg5 WT MEF, and 
compared with Atg5 WT MEF, it responses differently to a series of stresses even cell 
death stimuli which may not be attributed to the lackage of autophagy (data not shown), 
We suspected that the genetic backgrounds of these two cell lines are quite different. So in 
order to identify the real deregulated miRNAs during autophagy induction, we mainly 
focused on the deregulated miRNAs in the samples of Atg5 WT MEF cells with or without 
6h EBSS treatment (microarray 7180040). 
Through Taqman Reverse Transcription quantitative PCR, we first examined the 10 
interested miRNAs’ expression in MEF cell treated with EBSS for 6 hour. As shown in 
Figure 3.3,   among the 10 interested miRNAs, 7 miRNAs (miR-181a, miR-221, miR-30c, 
miR-93, miR-99, miR-199a, let-7b) showed expression patterns consistent with microarray 
7180040. miR-34a whose signal was not readable in the microarray showed no 
deregulation. And we also found two miRNAs, miR-17 and miR-99a, showed a 
downregulation trend to some degree while miR-30c showed a slight upregulation. The 
upregulation of miR-181a & miR-93 and the downregulation of miR-221 were statistically 
significant (p-value<0.05). Thus the deregulation of the three significantly deregulated 
miRNAs (miR-181a, miR-93 and miR-221) revealed by microarray were validated by the 



























Figure 3.3 Validation of the interested miRNAs’ deregulation in Atg5 WT and GFP-
LC3 MEF in starvation and Rapamycin induced autophagy. (A) Normalized 










was induced following 6h EBSS treatment. (B) Normalized expression level of miR-181a, 
miR-221 and miR-93 in Atg5 WT MEF when autophagy was induced following 3h 
Rapamycin (100nm) treatment. (C) Normalized expression level of miR-181a, miR-221 
and miR-93 in GFP-LC3 MEF when autophagy was induced following 6h EBSS treatment. 
(D) Normalized expression level of miR-181a, miR-221 and miR-93 in GFP-LC3 MEF 
when autophagy was induced following 3h Rapamycin (100nm) treatment. (E) The other 7 
interested miRNA expression level in Atg5 WT MEF when autophagy was induced by 6h 
EBSS treatment. The miRNA levels were measured by Real Time qRT-PCR and 
normalized against the internal control snoRNA202 or snoRNA234. Error bar presents 
standard error of at least 3 independent experiments. * means p-value <0.05. 
 
                  We proceeded to examine whether the deregulation of these three miRNA in Atg5 
         WT MEF following 6h starvation treatment was indeed due to autophagy induction, by 
         employing another autophagy inducing agent Rapamycin and another MEF cell line GFP- 
         LC3 MEF. Rapamycin has been shown by a lot of studies to be able to efficiently block 
          mTORC1 activation and thus lead to autophagy induction even in the nutrient rich 
          condition (Noda and Ohsumi, 1998). Figure 3.4 shows autophagy is induced in both Atg5 
          WT MEF and GFP-LC3 MEF following EBSS treatment (starvation) or 100 nm 
          Rapamycin treatment. During autophagy, LC3-I is converted to LC3-II; p62 level is 
          decreased, especially in starvation induced autophagy. EBSS and Rapamycin treatments 
           lead to deactivation of mTOR signaling pathway as evident from the dephosphorylation 
           of two mTOR downstream targets - p-S6 and p-4E-BP1. In GFP-LC3 MEF cells, the 




























Figure 3.4  Autophagy induction in Atg5 WT MEF and GFP-LC3 MEF cells. Western 
blot shows that autophagy is induced after EBSS treatment and Rapamycin  treatment for 3 
hour and 6 hour in Atg5 WT MEF cell (A) and GFP-LC3 MEF cell (B). (C) morphological 
character of starvation induced autophagy and Rapamycin induced autophagy in Atg5 WT 
MEF cell; (D) Autophagy is induced in GFP-LC3 MEF cell following 6h  EBSS treatment 





Atg5 WT MEF 
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punctas. CDP is the lysosomal inhibitor which can block the LC3-II degradation and thus 
be  used in detecting the intracellular  autophagic activity. 
 
Using the same set of cells, we then focused on the endogenous expression of miR-
93, miR-181a & miR-221 in these two cell lines after 6h EBSS treatment or 3h 100nm 
Rapamycin treatment which has already been proved to successfully induce autophagy. As 
shown in Figure 3.3, consistent with the microarray and the previous validation, miR-93 
and miR-181a were upregulated in starvation induced autophagy while miR-221 showed a 
consistent downregulation in starvation induced autophagy. In addition, compared with the 
miRNA expression patterns of starvation induced autophagy, all three miRNAs showed 
similar expression patterns in Rapamycin induced autophagy in both Atg5 WT MEF and 
GFP-LC3 MEF cells. Interestingly, the degree of deregulation for these three miRNAs in 
starvation induced autophagy and Rapamycin induced autophagy were also similar. These 
demonstrated that the deregulation of these three miRNAs was indeed due to autophagy 
induction, indicating the potential important regulatory role these three miRNAs might 
have on autophagy. Thus a miRNA signature in autophagy induction was revealed. 
Since there exists distinct differences between effects of Rapamycin treatment and 
effects of amino acid starvation (Peng et al. 2002), the common effect of Rapamycin 
treatment and EBSS treatment placed on the expression of these three miRNAs implyed 
that target genes of these three miRNAs regarding to autophagy regulation should be more 
downstream, possiblely, genes involved in the autophagy core machinery. 
      




We then proceeded to screen the potential autophagy related target genes of these   
miRNAs. miR-93 was selected as the first miRNA to be functionally investigated because 
in MEF cells, it showed consistently steady upregulation in both EBSS and Rapamycin 
induced autophagy and has more predicted Atg target genes compared with the other two 
miRNAs (Table 3.3). 
Pre-miR™ miRNA Precursors, small chemically modified double-stranded RNAs 
which includes one strand that is identical to the particular mature miRNA, are designed to 
mimic endogenous precursor miRNAs. Upon transfection into the cells, miRNA precursors 
are being processed into mature miRNA using the miRNA processing pathway of the host 
cell, thus the specific miRNA is overexpressed  which will cause an increase in target 
mRNA suppression. Likewise, negative control miRNA is being processed into a miRNA 
that is validated not to bind any target genes. In contrast, Anti-miR™ miRNA Inhibitors, 
small chemically modified single-stranded RNAs, are designed to bind to and subsequently 
inhibit the activity of specific endogenous miRNAs. 
In order to examine the possible regulatory role of miR-93 on autophagy, Pre-miR-
93, Anti-miR-93 and negative control miRNA were also transfected transiently into Atg5 
WT MEF and GFP-LC3 MEF cells.    
As shown in Figure 3.5, upon transfection of miR-93 mimic into the Atg5 WT MEF 
or GFP-LC3 MEF cells, the amount of mature miR-93 was greatly enhanced while it was 
also dramatically decreased when antagomir of miR-93 was introduced into the cells.  The 
intracellular basal autophagic activity was reduced in the pre-miR-93 transfected GFP-LC3 
MEF cells while it was increased in the anti-miR-93 transfected GFP-LC3 MEF cells, 
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comparing with that of GFP-LC3 MEF cells transfected with negative control miRNA. 
When the transfected cells were treated with EBSS or 100nm Rapamycin for 3 hour, there 
was an obvious autophagy induction in all three populations of cells, similarly, the pre-
miR-93 transfected cells again showed a relatively weak autophagy induction while the 
anti-miR-93 transfected cell showed a stronger autophagy induction compared to the 
control group of cells (Figure 3.6 A, B). And the pattern of endogenous autophagy activity 
in these three populations of cells correlated well with the expression pattern of Ulk1 and 
STAT3. As STAT3 was already a proven target of miR-93, this result supported the 
hypothesis that miR-93 placed a negative regulatory effect on autophagy induction via 
targeting Ulk1, one of the core autophagy machinery genes involved in the autophagy 
initiation process. Figure 3.6 C showed the confocal microscopy images of the three 
transfected groups of GFP-LC3 MEF, as evidenced by the change of area and numbers of 
GFP-LC3 punctas, this result confirmed miR-93’s negative effect on starvation and 





















Figure 3.5 The efficiency of transient transfection in MEF cells. (A) Mature miR-93 
expression level in Atg5 WT MEF cells after transfected with negative control, miR-93 precursor 
or miR-93 inhibitor for 24h. (B) Mature miR-93 expression level in GFP-LC3 MEF cells after 
transfected with negative control, miR-93 precursor or miR-93 inhibitor for 24h. Data presented 














































































and Rapamycin induced autophagy. (A) Western blot image showing miR-93 
negatively regulates cellular autophagic activity in starvation-induced autophagy. GFP- 
LC3 MEF cells were transfected with 100 nm negative control miRNA, pre-miR-93, anti- 
miR-93 respectively. 24h post transfection, cells were treated with EBSS for 3h. The 
control groups were cultured in full medium. 10 um CDP was added as an inhibitor of 
autophagic process at late stage to show the real autophagic flux. (B) Western blot image 
showing miR-93 negatively regulates cellular autophagic activity in rapamycin-induced 
autophagy. The same set of three transfected GFP-LC3 MEF cells were treated with 100 
nm Rapamycin for 3h. Image J software was used to quantify LC3-II expression and the 
values which are listed above the row of actin were the relative fold change normalized to 
the control group. (C) Confocal microscopy image of starvation or Rapamycin-induced 
autophagy in GFP-LC3 MEF cells transfected with 100 nm negative control miRNA, miR- 
93 mimic and miR-93 antagomir, respectively. GFP-LC3 puncta/cell was counted 
manually for each group. Data presented are mean ± S.E. * denotes a p-value less than 
0.05. 
 
3.4 Screening of possible autophagy related target genes of miR-93 
 
Employing miRecords (http://mirecords.biolead.org) which combines the results of 
11 microRNA-target prediction programs including miRanda, PicTar & TargetScan (Xiao 
et al., 2009), an in silico screen for the autophagy related target gene of miR-93 was first 
conducted. A prediction was considered valid only if the target relationship was predicted 
by at least 3 programs. 
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As briefly summarized in Table 3.4, miR-93 was predicted to target a series of 
autophagy related genes (both in the autophagy upstream regulatory network and the 
autophagy core machinery) including Ulk1, Hif1a, STAT3, Eif4g2, BNIP2, Bcl2l2, E2F1, 
Atg16l1, Rb1cc1, XIAP, Bcl2, Bcl2l11, BNIP3, Mapk1, Atg2a, Atg2b.  
 
          Table 3.4 Predicted autophagy related target genes for mmu-miR-93 
Target Gene 
Base  Pairing 
Complementarity 
Conserveness 
No. of Programs 
Predicting the 
Relationship 
Ulk1 partial Mouse,Human 5 
Hif1a partial Mouse 5 
STAT3 partial Mouse,Human,Rat 5 
Eif4g2 partial Mouse,Human 5 
Rb1cc1 partial Mouse,Human 4 
Bnip2 partial Mouse,Human 4 
Bcl2l2 partial Mouse,Human 4 
E2F1 partial Mouse,Human 4 
Atg16l1 partial Mouse,Human 4 
Atg7 partial Mouse,Human 3 
XIAP partial Mouse 3 
Bcl2 partial Mouse 3 
Bcl2l11 partial Mouse 3 
Bnip3 partial Mouse 3 
Mapk1 partial Mouse 3 
Atg2a partial Mouse,Human 3 
Atg2b partial Mouse,Human 3 
Akt1 partial Mouse, Human  3 
 
         3.4.1 miR-93 negatively regulates Ulk1 expression 
 
         To identify the possible target genes, we selected 7 predicted target genes for further 
examination based on the number of programs predicting the relationship, the importance 
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of target gene in the autophagy network and their conserveness among species. Target gene 
expressions were examined at both protein level and mRNA level. 
GFP-LC3 MEF were transfected with negative control miRNA, mimic and 
antagomir of mmu-miR-93 (100nm) and the level of selected target gene transcripts were 




































Figure 3.7  The mRNA expression level of miR-93 predicted target genes after 
transfected with 100nm negative control miRNA, mimic and  antagomir of miR-93. 
(A) The mRNA levels of predicted target genes in transfected GFP-LC3 MEF. (B) Ulk1 
mRNA level in transfected Atg5 WT MEF. (C) STAT3 mRNA level in transfected Atg5 
WT MEF. 24 hours post-transfection, cells were harvested and the target gene transcript 
level were measured by Real time qRT-PCR and normalized to b-actin. Data were 










Among those predicted target genes, mRNAs of STAT3 and Ulk1 were 
downregulated upon addition of pre-miR-93 into the GFP-LC3 MEF cells while they were 
relatively more abundant when anti-miR-93 was introduced into the GFP-LC3 MEF cells. 
To confirm this, Atg5 WT MEF was also transiently transfected with mimic and antagomir 
of miR-93, indeed, the mRNA levels of Ulk1 and STAT3 were decreased upon pre-miR-93 
transfection (Figure 3.7 B, C). Based on this result, STAT3, Ulk1 seemed to be the real 
target of miR-93 in Atg5 WT MEF and GFP-LC3 MEF cells. 
After observing miR-93’s negative regulatory effect on autophagy induction, we then 
focused on elucidating the relationship between miR-93 and its predicted target gene, Ulk1. 
STAT3 has also been proved as a miR-93 target in mouse (Foshay et al., 2009). 
As shown in Figure 3.8, the protein expression of Ulk1 was suppressed when miR-93 
precursor was introduced into the Atg5 WT MEF and GFP-LC3 MEF cell. Also, 
transfection of miR-93 antagomir weakened miR-93’s suppression on Ulk1 as evidenced 
by an increase in the protein expression. Similarly, STAT3 protein expression level was 
also decreased when miR-93 precursor was transfected into the cells while it was relatively 
higher when cells were transfected with miR-93 antagomir, compared with that of cells 
















Figure 3.8 miR-93 negatively regulates Ulk1 protein expression. (A) Protein expression   
of Ulk1 in Atg5 WT MEF cells transfected with100nm negative control miRNA, miR-93 
precursor or miR-93 inhibitor. (B) Protein expression   of Ulk1 in GFP-LC3 MEF cells 
transfected with100nm negative control miRNA, miR-93 precursor or miR-93 inhibitor. 
Image J software was used to quantify Ulk1 and STAT3 protein expression and the values 
listed below protein bands were the relative fold changes normalized to the control group.  
 
3.4.2    Ulk1 is downregulated at specific time points when autophagy is induced 
 
At the same time when the screen for miRNA target was conducted in the transfected 
MEF cells, the protein expression of interested autophagy related gene was also being 
examined in both Atg5 WT MEF and GFP-LC3 MEF under conditions of EBSS induced 






If the target gene was indeed a major endogenous target of the specific miRNA, it 
might present an opposite expression trend compared to the expression pattern of the 
miRNA regulator. 
Although the autophagy process was still on-going, as evidenced by the 
accumulation of LC3 II under both EBSS and Rapamycin treatment (Figure 3.9), Ulk1, one 
of the core Atg genes involved in the initiation step of autophagy, showed a 
downregulation trend at specific time points in starvation and Rapamycin triggered 
autophagy induction. Interestingly, miR-93 was previously proved to be upregulated at the 
same time points (Figure 3.3), indicating that Ulk1 may be a real endogenous target of 
miR-93.  
STAT3 was proved to be an endogeneous target of mmu-miR-93 (Foshay et al., 
2009). So we employed it as a positive control to indicate the possible target genes of 


































   
Figure 3.9 Downregulation of Ulk1 in autophagy induction in Atg5 WT and GFP-
LC3 MEF cells. (A) Western blot results showing Ulk1 downregulation in Atg5 WT MEF. 







treated with EBSS or 100nm Rapamycin for 3 hour or 6 hour. Image J software was used 
to quantify Ulk1 and STAT3 protein expression and the values listed below protein bands 
were the relative fold changes normalized to the control group. 
 
3.5   Ulk1 is a direct target of miR-93 
 
To answer the question whether miR-93 directly regulatesUlk1 expression by 
binding to the predicted binding sites located in the 3’ UTR of Ulk1 mRNA, we used β-
Galactosidase reporter gene assay to elucidate the molecular mechanism. We first 
identified two putative miR-93 binding sites in the 3’ UTR of Ulk1 mRNA using 
Targetscan prediction program. Then the 1683 bp long wildtype Ulk1 3’ UTR as well as 
the corresponding mutant Ulk1 3’ UTR in which the two putative binding sites for miR-93 
were mutated were subcloned into the downstream of the β-Galactosidase reporter gene 
driven by MRP1 promoter. When HCT116 cell were transfected with 50nm miR-93 
precursor, a significant reduction of β-Galactosidase activity was observed in cells carrying 
the wildtype Ulk1 3’UTR reporter construct compared to cells carrying the mutant Ulk1 
3’UTR reporter construct. And there was no significant difference in the β-Galactosidase 
activity between cells carrying the wildtype Ulk1 3’UTR reporter construct and cells 
carrying the mutant Ulk1 3’UTR reporter construct when negative control miRNAs were 
introduced into the cells. Figure 3.10 shows that miR-93 can specificaly interact with the 























Figure 3.10  miR-93 interacts with the predicted binding sites on Ulk1 3’UTR. (A) 
Schematic diagram of the constructs pUlk1-3UTR-WT with the two predicted binding sites 
and corresponding mutant binding sites.  “X” means the predicted targeting relationship 
does not exist when the specific predicted binding site on the 3' UTR of Ulk1 mRNA was 







predicted sites in Ulk1 mRNA 3’UTR. Data presented are mean ± S.E. of three 



















































Chapter 4    Discussion and Conclusions 
 
4.1    Autophagy-miR-93-Ulk1 negative feedback loop 
 
One important observation from this study is that, we identified a novel negative 
regulatory function of miR-93 on autophagy, which is at least, partially, executed by 
targeting Ulk1 gene expression. Autophagy induced by both starvation or Rapamycin leads 
to significant up-regulation of miR-93. On the other hand, miR-93 is able to negatively 
regulate autophagy via suppression of Ulk1 gene expression. Therefore, it is believed that 

















At present, it is still controversial, at least in the mammalian cells, whether 
autopahgy requires de novo gene transcription and protein synthesis (Martinet et al., 2006; 
Mizushima et al., 2007). On one hand, it is widely believed that Atg proteins are always 
sufficiently expressed and their post-translational modifications and/or associations with 
other members of the autophagic machinery seem more critical to autophagy rather than 
the regulation on their expression levels (Mizushima et al., 2010);  on the other hand, some 
of the key Atg proteins such as LC3 are found to be significantly up-regulated in the 
autophagic process (Xiao et al., 2011).  Therefore, it is highly possible that there are active 
regulatory mechanisms at the transcriptional and translational levels in the course of 
autophagy. Data from this study provided new evidence that certain miRNAs could play 
important roles in autophagy via regulation of key Atg genes such as Ulk1. Our findings 
are generally consistent with the existing reports showing that miRNAs could target other 
Atgs such as Beclin 1, LC3-II (Zhu et al., 2009; Xiao et al., 2011).  
A possible explanation of this negative feedback loop involving miR-93 is that when 
cells are under stress conditions, autophagy is induced to provide cells with essential 
regenerated energy and “building blocks” such as amino acids, however, the autophagy 
activity should be tightly limited to a certain degree otherwise the excessive autophagy 
activity would destroy the normal cellular system and render cells to autophagic cell death 
(Codogno et al., 2005; Kang et al., 2007). Thus, miR-93 may help cells to survive by 
limiting the harmful excessive autophagic activity. It is also possible that extra Ulk1, like 
extra Atg5 (Yousefi et al., 2006),  may interact with other signal molecules, lead it to 
detrimental outcomes such as promoting apoptosis, so cells have to generate some 
inhibitors to decrease the total expression of Ulk1 to an acceptable level. 
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However, it should be noted that during autophagy induction, the upregulation of 
miR-93 does not result in a complete blockage of the Ulk1 expression or the corresponding 
autophagy induction process. Autophagy is still ongoing under starvation and Rapamycin 
treatment which might be explained by the fact that even a small amount of Atg1 is often 
enough for the initiation of autophagy (Kabeya et al, 2009). Therefore, further studies are 
needed to determine the actual functional impact of miRNAs such as miR-93 on autophagy 
and whether such regulatory mechanisms could serve as new venue for the intervention of 
autophagy.  
 
 4.2   miR-93 deregulation affects multiple pathways 
  
Autophagy deregulation is a common phenomenon in many human diseases, 
especially in cancer. So far, autophagy is much more perceived as a tumor suppressive 
process (Huang et al., 2007), as a lot of previous studies have demonstrated that tumor cells 
showed  reduced autophagic activity  (Schweers et al., 1985;  Knecht et al.,1984) and 
several anticancer drugs as well as tumor suppressor genes such as PTEN and p53 exert a 
favorable effect on autophagy induction (Kondo and Kondo, 2006).  
Nevertheless, miR-93 is a component of the miR-106b-25 polycistron which  exert 
potential proliferative, antiapoptotic, cell cycle-promoting effects in vitro and tumorigenic 
activity in vivo. The miR-106b-25 cluster is a paralog of the miR-17-92 cluster based on 
the similarity between their nucleotide sequences.     
Human miR-93 was observed to be frequently upregulated in a series of tumors 
including epithelial ovarian cancer (Resnick et al., 2009), T-cell leukemia (Yeung et al., 
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2008), hepatocellular carcinoma (Li et al., 2009b), highgrade breast tumors (Blenkiron et 
al., 2007), gastric cancer (Petrocca et al., 2008; Kim et al., 2009), prostate cancer (Ambs et 
al., 2008) as well as stress conditions such as hypoxic environment in primary term human 
trophoblasts (Donker et al., 2007). Its downregulation was also being observed in HCT-8 
and HCT-116 colon cancer cells after treatment with 5-fluorouracil (5-FU) and oxaliplatin 
(L-OHP) (Zou et al., 2010) as well as cells undergo cardiac hypertrophy (Van Rooij et al., 
2006). 
Generally, miR-93 is considered as an oncomiR and affects a variety of signaling 
pathways: 
The miR-106b-25 cluster including miR-93, was proven to be activated by E2F1 in 
human gastric cancer in parallel with its host gene, Mcm7 and in turn, negatively regulated 
E2F1 (Petrocca et al., 2008). As E2F1 is a transcription factor that transactivates a variety 
of genes involved in chromosomal DNA replication and both oncogenic and tumor 
suppressive activities, the effects of downregulation of E2F1 by miR-93 may be quite 
complex. For instance, with regard to autophagy, E2F1 upregulates several autophagy 
genes including LC3, Atg1, Atg5, DRAM (Polager et al., 2008) and BNIP3 (Tracy et al., 
2007), but it also activates PI3K/Akt/mTOR pathway (Ladu et al., 2008). Suppression of 
E2F1 by miR-93 may subsequently lead to suppression of target genes of E2F1 and 
subsequent effects.  
Indeed, besides directly targeting E2F1, miR-93 was also proved to target several 
E2F1 upregualted genes including cell cycle regulator p21 (Petrocca et al., 2008) and the 
tumor suppressor TP53INP1 (Yeung et al., 2008). Overexpression of miR-93 completely 
abrogated TGFβ-induced cell-cycle arrest, it is consistent with the degree of p21 
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downregulation.  And targeting another tumor suppressor gene FUS1 could also decrease 
apoptosis (Maes et al., 2008).  
Through luciferase reporter assay and western blot, STAT3 was proved to be a target 
of miR-93 (Foshay et al., 2009). Similar to targeting E2F1, targeting the pluripotent 
transcription factor STAT3 could also lead to alteration in a lot of downstream processes. 
 
4.3   Autophagy induction induces deregulation of miRNAs   
          
As described in Section 3.1, from the microarray, several clustered miRNAs were 
found to be deregulated in starvation-induced autophagy. The coordinated deregulation of 
members of a specific miRNA family or members of different families which shares the 
common target genes implies that the miRNA families may have a combinational effect on 
the regulation of autophagy. For example, Bcl-2 is the common predicted target of both 
upregulated miRNAs – miR-93 and miR-181a, as well as the downregulated miRNA miR-
221 (Table 3.3), suggesting that these miRNAs may contribute to the balance of 
endogenous Bcl-2.  Since Bcl-2 familiy members play important roles in both autophagy 
and apoptosis (Pattingre et al., 2005), the  change of intracellular Bcl-2  homeostasis would 
affect both autophagy and apoptosis.   
In addition, from the screening for the possible miRNA regulators of autophagy, we 
found that miRNAs previously identified to target key Atg genes were rare in the 
microarray report. For those miRNAs that are predicted to target key Atg genes, usually 
they are also predicted to target  dozens of other genes involved in autophagy upstream 
signaling network and other types of programed cell death, both proautophagic and 
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antiautophagic (Table 3.3), so it is hard to estimate the dominant role that these miRNAs 
would play in the regulation of autophagy induction, completion and function. As miRNA 
regulation is such a dynamic process, it is very possible that during different stages of 
autophagy process, a specific miRNA may have different major targets and play distinct 
functions (Arnold et al., 2011; Ambros and Chen, 2007). 
In order to obtain more consistent deregulation of miRNAs in autophagy induction, 
we employed another autophagy inducing agent Rapamycin and another MEF cell line. 
Based on our data, there is not much significant difference in the level of expression of the 
three miRNAs examined following the two different ways of inducing autophagy (Figure 
3.3).  Nevertheless, further study wil reveal the different expression patterns of other 
miRNAs following these two treatments. This could be the result of a series of factors such 
as cell line or treatment specific effect on the expression of miRNAs. It is also possible that 
this is not associated with induction of autophagy. For example, Rapamycin has different 
effects on a lot of signaling pathways compared with EBSS treatment (Peng et al. 2002), 
the altered expression of a specific miRNA may be due to an alteration in a corresponding 
pathway not related to autophagy. 
 
4.4    Conclusions 
 
         Through this study, we identified a new target for mmu-miR-93, and elucidated the 
negative regulatory effect of miR-93 on autophagy induction was at least, partially, 
executed by decreasing Ulk1 expression. 
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It  has  been suggested that Atg mRNA or protein expression levels are not 
considered appropriate indicators for monitoring autophagy as Atg proteins are always 
sufficiently expressed and their post-translational modifications and/or associations with 
other members of the autophagic machinery seem more critical to autophagy rather than 
the regulation on their expression levels (Mizushima et al., 2010). This study agrees with 
the general notion that the expression levels of Atg genes are not proper autophagy markers, 
however, it does provide an evidence that through regulating the total expression of Atg 
genes, miRNA does have the ability to affect intracellular autophagic activity. 
Through this study, a new negative feedback loop in autophagy induction was 
revealed, showing that the induction of autophagy is under tight control in the intracellular 
environment. We can expect there will be more miRNAs being recognized as endogenous 
regulators of autophagy. 
 
4.5    Directions for future study 
 
          4.5.1  miRNA profiling following different autophagy induction stimuli and using different cell 
           lines 
 
 One weakness of this study is that  the miRNA microarray was conducted once only, 
using one autophagy induction stimuli - starvation, and the employment of two cell lines 
with distinct genetic backgrounds  further weaken the significance of the comparisons in 
the three designed experiments. The deregulations of miRNA expression revealed by the 
microarray may not be consistent and functionally-related as experiment conditions could 
cause a lot of deviation in the real miRNA expression and thus results in false leads. 
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More microarrays conducted under different autophagy induction conditions 
including nutrient deprivation, Rapamycin treatment and hypoxia are expected to reveal the 
consistent miRNA signature in autophagy induction and thus facilitate  future functional 
studies. 
Human cell lines, especially cancer cell lines which showed  deregulated basal or 
induced autophagy activity should  also be selected for the miRNA analysis. In addtion, 
cell lines which always showed the deregulation of the interested miRNAs should also be 
selected to study their autophagy activity. For example, miR-93 is deregulated in HCC, it is 
interesting to examine whether miR-93 also suppress autophagy in HCC and thus 
contributes to tumorigenesis. These will enhance the clinical relevance and prospect of this 
study.  
 
4.5.2 Characterization of the roles that miRNAs play in the biological functions of 
autophagy 
 
          As autophagy is closely related to cell death and survival, it will be interesting to 
examine the effect of miRNAs (especially oncomiR and tumor suppressor miRNAs) on 
cell death, survival and proliferation via monitoring autophagy, thus further revealing 
miRNA and autophagy’s biological function in the various physiological and pathological 
conditions. 
 




As mentioned in 1.1.4, autophagy deregulation is a common phenomenon in many 
human diseases. The investigation of miRNAs’ effect in pathogenesis via monitoring 
autophagy will contribute to the better understanding of the molecular mechanisms of 
diseases and bring possible breakthrough points for developing miRNA-based therapies. 
For example, regarding  the oncogenic miR-93's negative regulatory effect on 
autophagy,  whether or not miR-93 also participates in affecting Ulk1 expression and 
autophagy in malignant cells remains to be clarified. It would  thus be important to further 
analyze if a direct correlation between the aberrant expression of endogenous miR-93 and 
disease development such as tumorigenesis via modulation of Ulk1 and corresponding 
autophagy. Clinical samples of different stages of cancer should be obtained for analyzing 
the expression level of miR-93, Ulk1 and other classic autophagic markers. In contrast, 
further investigation is also required to determine in the condition of environmental and 
metabolic stresses such as nutrient deprivation and hypoxia, whether autophagy also exerts its 
protective effect via enhanced expression of miR-93 and consequent suppression of target 
genes such as E2F1 and STAT3. 
Besides, miR-93 was also found to have the ability to accelerate the accumulation of 
toxic agent in aging liver isolated from 33 month old mouse as it targeted several important 
genes involved in maintaining the intracellular homeostasis and detoxification such Mgst1 
& eEF1A-1 (Maes et al., 2008).  miR-93 might also downregulate autophagy through 
decreasing Ulk1 expression in this condition. As autophagy is  crucial for maintaining the 
intracellular homeostasis by providing energy and eliminating spent organelles and other 
cytotoxic components. The negative effect of miR-93 on autophagy thus may contribute to 
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the deterioration of cytotoxic environment which can lead to malfunction of aging liver and 
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